A great brand on sale, or a value trap?

Few brands have fallen as far, as fast. The athleisure pioneer that spent a decade as a Wall Street favorite, maker of the premium leggings that built a cult following, now trades at $105, a 5-year low, down about 55% over the past year after a June 4 guidance cut. Here’s the twist: it’s no longer priced like the growth story it was. At roughly 8 times earnings, with a double-digit free-cash-flow yield and a 32% return on equity, the market has re-rated it to a value stock. The only question that matters is whether the earnings base is durable, or still falling. Cheap, or cheap for a reason?

Key Takeaways

• The fall is brutal. Lululemon is down about 55% over the past year, sitting at a 5-year low near $105 after cutting its full-year guidance on June 4.

• The business is softening, not collapsing. Revenue still grew 4% over the past year and the company earns a 13% net margin, but comparable sales in the Americas fell 5% last quarter (the fifth straight decline), gross margin is under tariff pressure, and earnings are falling for a second year.

• It’s genuinely cheap. The stock trades at about 8 times trailing earnings, 1 times sales, and roughly 5 times debt-adjusted profits, with a near-10% free-cash-flow yield on trailing numbers, a value-stock price tag on what was a premium-growth name.

• The damage is geographic. The Americas, its biggest market, is shrinking (comps down 5%), while China still grew 23% last quarter, so the problem is the mature home market, not the brand everywhere. Whether that Americas weakness is cyclical or the start of brand fatigue is the whole debate.

• The overhangs are clearing. The proxy fight with founder Chip Wilson was settled in May, and a 26-year Nike veteran, Heidi O’Neill, takes over as chief executive in September. Analysts rate it a hold, with an average target near $132, about 25% above the price.

Start with how a darling became a discard.

From Growth Darling to Value Stock

For years, Lululemon was the rare retailer that could do no wrong. It built a cult brand around premium yoga and athletic wear, charged full price, almost never discounted, and grew revenue at a 19% clip as recently as a couple of years ago. That growth is gone. Revenue rose about 19% in the year to early 2024, then 10%, then just under 5% this past year, and management now guides to roughly flat sales for the year ahead.

Earnings have followed: diluted earnings per share peaked near $14.64, slipped to $13.26 last year, and are guided down again to about $11 this year. When a market darling stops growing, the stock doesn’t drift, it re-rates violently. A name that once commanded 35 or 40 times earnings now trades at 8.

What Went Wrong

Several things hit at once. First, the Americas, by far its biggest market, went into reverse: comparable sales, the standard retail gauge of how existing stores are doing, fell 5% last quarter, the fifth straight quarterly decline, and management expects Americas revenue to drop high-single-digits for the year.

Management argues some of that softness was transitory, the proxy fight and questions about a few products’ materials, and says the worst of that noise has faded, though it concedes trends haven’t recovered. Either way, the home market is shrinking.

Second, margins. Gross margin fell 410 basis points last quarter, to 54.2%, and management warned that tariffs and stepped-up investment will keep weighing on profitability, the very thing that justified the premium multiple in the first place.

Third, the boardroom. The company spent much of the year in a public proxy fight with founder Chip Wilson, a vocal critic of its current direction; the board fired back, branding his perspectives “misguided” and “outdated.”

It’s now settled: Wilson placed a pair of nominees on the board in late May, and a permanent chief executive, 26-year Nike veteran Heidi O’Neill, takes over in September, replacing an interim team. The leadership cloud is lifting, even if the business hasn’t yet turned.

What Didn’t Break

For all that, the franchise isn’t broken everywhere. China, now about 19% of sales, grew 23% last quarter and remains a genuine growth engine, and the international business as a whole is still expanding, even if a backlash against Western brands and tougher local competition make that growth harder to bank on.

The damage is concentrated in the mature Americas, not spread across the brand, which is the difference between a company in structural decline and one with a big-market problem. And the financials underneath are still those of a premium franchise: a 55.7% gross margin, a 32% return on equity, more than $1.1 billion of free cash flow, and modest debt.

What the Numbers Say

Here’s the contradiction in one frame. Those franchise-quality financials now come at a distressed price: the stock trades at about 8 times trailing earnings, 9 times forward, barely 1 times sales, and roughly 5 times enterprise value to EBITDA (a debt-adjusted earnings multiple), with a free-cash-flow yield near 10% on trailing numbers.

The catch is the trajectory. Revenue growth has slowed to about 4%, and earnings per share are heading lower for a second straight year, from $14.64 to $13.26 to a guided $11. A cheap multiple on falling earnings is the textbook setup for a value trap, and it’s why the stock keeps making new lows even as it “looks cheap.”

The point isn’t that the market thinks Lululemon is a bad business; it’s that the old earnings base may no longer deserve the old multiple. The bull case is that the brand is still elite and a double-digit cash yield pays you to wait for the turn. The bear case is that the multiple is cheap because earnings are still falling, and nobody knows where they stop. Both can be true for a while.

What the Tape Says About Timing

The fundamentals are the thesis; the tape is just the timing, and it offers no comfort yet. At $105, Lululemon sits below every major moving average; it trades roughly 39% below its 200-day, which is up near $172, a measure of how relentless the downtrend has been. Its daily relative strength index, a 0-to-100 momentum gauge where under 30 signals oversold, is at 27, with the weekly reading at 30, so the stock is stretched to the downside and due for a bounce.

But oversold in a strong downtrend isn’t the same as a bottom. Until Lululemon can reclaim some of those falling averages, every rally is suspect, and the path of least resistance stays lower.

Here’s how I’m reading the levels.

Levels We’re Watching

This is a falling knife with a cheap valuation, the kind of setup where patience beats heroics. These are levels to watch, not instructions.

Read more

Same theme, same beat-and-fade, very different price tags.

Cybersecurity has been the trade of the spring: between April and late May, Palo Alto Networks (PANW) and CrowdStrike (CRWD) each jumped more than 70%, helped along by “Mythos,” an AI model so good at finding software flaws that its maker held it back. Then both reported in early June, both beat and raised guidance, and both stocks fell anyway, CrowdStrike about 8%, Palo Alto about 3%. That’s what a stretched setup does.

The question the selloff left behind is the good one: why does the market pay so much more for CrowdStrike than for the bigger, cheaper, cash-richer Palo Alto?

Key Takeaways

• Both are winning. Palo Alto’s revenue rose 31% to $3 billion last quarter (helped by acquisitions), and CrowdStrike’s recurring revenue base grew 24% to a record $5.5 billion. Demand for security keeps compounding.

• The prices aren’t the same. CrowdStrike trades near 34 times sales and 110 times forward earnings; Palo Alto near 22 times sales and 70 times forward, roughly a third cheaper on both.

• Both are cash machines, but reported profits are noisy. Palo Alto generated $3.58 billion in free cash flow yet posted a small GAAP loss last quarter on acquisition costs; CrowdStrike threw off $1.93 billion in cash and just swung back to a small GAAP profit, though it’s still around breakeven over the trailing year.

• Both beat and both fell. After a 70% run, even a record quarter wasn’t enough: CrowdStrike’s beat was thinner than usual, and that’s all a stock priced for perfection needed to drop 8%.

• Wall Street still likes both, rating each a buy. But Palo Alto’s setup is calmer (a 0.94 beta, near record highs) while CrowdStrike (1.24 beta) has pulled back about 13% from its high.

Start with the bigger, cheaper one.

Palo Alto Networks (PANW): The Cash Machine

Palo Alto is the elephant of cybersecurity, a $235 billion company built by bundling a sprawling set of security products, network firewalls, cloud security, and AI-driven security operations, into one suite it sells to big enterprises as a single vendor. The strategy is consolidation: get customers to replace a dozen point products from a dozen suppliers with Palo Alto’s all-in-one offering.

The latest quarter showed it’s working, with a caveat. Revenue grew 31% to $3 billion, but about $388 million of that came from its recent CyberArk and Chronosphere acquisitions, so ex-deals the top line grew only in the low-to-mid teens. The stronger organic signal is next-generation security annual recurring revenue (the run-rate of its subscription sales), which reached $8.1 billion, up 60% with the deals and a still-healthy 28% without them.

The contracted backlog, what the company calls remaining performance obligations, grew 36% to $18.4 billion, demand locked in for future quarters. Palo Alto raised its full-year guidance across the board.

Here’s what sets it apart: cash. Palo Alto generated $3.58 billion in free cash flow over the past year, earned $0.85 of adjusted (non-GAAP) profit per share last quarter, and carries almost no debt, with management targeting a 40% free-cash-flow margin by fiscal 2028.

The reported numbers are messier, the latest quarter was actually a small GAAP loss, about $0.22 a share, on roughly $200 million of CyberArk-related costs and heavy stock-based compensation, but the underlying cash engine is real and growing. The stock isn’t cheap, near 70 times forward earnings and 22 times sales, but you’re paying for a cash-generative leader, not a promise.

Wall Street is on board: 50 analysts rate it a buy, and after the quarter Goldman Sachs lifted its target to $330 and Citi to $340, both above today’s $288. The bigger caveat is the CyberArk deal itself, a roughly $25 billion acquisition that has to be digested without tripping up the core business.

Net read: the blue-chip way to own cybersecurity. Cash-rich, diversified, lower-beta, and growing, but priced for it, and now leaning on a giant acquisition to keep the top line moving.

CrowdStrike (CRWD): Priced for Perfection

CrowdStrike is the purebred. Where Palo Alto sells everything, CrowdStrike built its name on one thing done exceptionally well: cloud-native endpoint protection, the software that guards the laptops, servers, and cloud workloads where attacks actually land. It’s widely seen as best-in-class, with elite customer retention and rich margins, a company-wide gross margin around 75% and subscription margins near 80%, and it has expanded outward into a broad security suite of its own.

The latest quarter was, by most measures, excellent: its recurring revenue base reached a record $5.5 billion, up 24%, revenue grew 26%, and it generated record cash flow. It even raised its growth outlook and announced a 4-for-1 stock split, effective in early July, a cosmetic move that doesn’t touch the valuation but tends to stoke retail interest.

So why did the stock drop 8%? Because “excellent” wasn’t enough. CrowdStrike’s net new subscriptions beat expectations by only a hair, a far cry from the blowout beats investors had grown used to, and for a stock trading at 34 times sales and 110 times forward earnings, merely good reads as a disappointment.

On a trailing-year basis it’s still around breakeven, a hangover from the July 2024 software update that crashed millions of computers worldwide, though it swung back to a small GAAP profit, about $28 million, in the latest quarter, and gushes cash underneath ($1.93 billion of free cash flow over the past year). The valuation leaves no room for error, which is exactly why a strong-but-not-spectacular quarter knocked it down.

Net read: the best-in-class pure play, and priced like it. The business is superb; the stock assumes it stays superb forever. After pulling back about 13% from its high, it’s cheaper than it was, but still the most expensive name in the group.

The Valuation Gap

Put the pair side by side and the real debate comes into focus. It isn’t which company is better, it’s which model deserves the premium. CrowdStrike is the smaller company, growing at a similar organic pace and only barely profitable on a trailing basis, yet it commands a higher multiple on every measure, 34 times sales against 22, and 110 times forward earnings against 70.

The market is paying up for its focus and its reputation as the gold standard, betting that a clean, high-margin pure play with the best retention compounds more reliably than a broader suite stitched together partly by acquisition. That’s a defensible bet: CrowdStrike’s land-and-expand model, where existing customers keep buying more modules, is genuinely powerful.

But the same gap is the risk. Palo Alto gives you a $3.58 billion cash engine, a lower beta, broader reach, and a cheaper price, in exchange for messier, acquisition-assisted growth and noisier reported earnings. CrowdStrike gives you the cleaner, higher-margin pure-play story at a price that assumes execution risk doesn’t exist, as the 8% drop on a good quarter just showed.

The interesting trades usually live where the market’s certainty is highest, and right now the market is very certain CrowdStrike deserves its premium.

The Technical Picture

Both look strong on the tape, but at different points in the move. Palo Alto sits near its record high around $303, above every major moving average, in a textbook uptrend that’s also a little stretched. Its daily relative strength index, a 0-to-100 reading where over 70 is overbought, is at 66, with the weekly hotter at 75.

CrowdStrike is the one that’s already exhaled. After topping near $786, it has slid about 13% to $685 on the earnings reaction, but it stays well above its rising 50-day and 200-day averages, so the longer uptrend is intact. Its momentum has cooled to a neutral 58, which, after a 70% run, looks more like a healthy reset than a breakdown.

How to Position

These are levels to watch, not instructions, based on prices as of the June 18 close, and both are high-multiple names where position size matters more than precision.

Read more

Market Conditions

The market spent a holiday-shortened week, with the cash session closed Friday for Juneteenth, consolidating last week’s recovery and then pushing it further, and the move had a clear character: the AI and semiconductor complex did not just hold its bounce, it broadened and accelerated.

QQQ rose 2.7% on the week to 740.62 and reclaimed a clean Trend-Hold, while SPY added 0.7% to 746.74 and small caps outperformed with the Russell up about 2%, even as the Dow finished roughly flat, a textbook tell that money was rotating toward growth and away from old-economy value. The Federal Reserve met Wednesday and held rates steady, and the front end firmed in response, the 2-year backing up to 4.19% from about 4.09% while the 10-year held near 4.46% and the 30-year sat at 4.90%, a modest curve-flattening the equity tape took in stride.

Volatility kept draining, with VIX-tracking products sliding through the week, and credit stayed calm, high-yield spreads steady, confirming a risk-on backdrop rather than a stress event. The leadership story was the AI-infrastructure surge: Nebius jumped 23% and CoreWeave 17% as the AI-compute names went vertical, Taiwan Semi rose 9%, Applied Materials 9%, Broadcom 8%, Intel 8%, and Lam Research 6%, dragging Alphabet, Nvidia, Broadcom, and Rubrik back into Trend-Hold and broadening the advance beyond the chips into megacap growth.

The flip side was the failure of last week’s defensive trade: the value, energy, and defense names that bounced a week ago rolled back over, with TechnipFMC down 8% and Exxon down 6% as energy broke down, Lockheed sliding 5% into Breakdown with Northrop falling 5% alongside it, and Walmart and Costco losing their repair and breaking down again.

Mega-cap software stayed broken, with Microsoft, Adobe, and Intuit all still in Breakdown and Apple still below its trend. With the Fed now behind us and no comparable catalyst on the near-term calendar, the tape is being driven by the AI-leadership rotation, and the path of least resistance stays higher so long as that leadership holds its trend.

What Changed From Last Week

• Reclaimed Trend-Hold: AVGO, CRWV, GOOG, NVDA, RBRK. The strongest signal of the week, structure fully repaired.

• Lifted out of Breakdown into Transitional: AMZN, SOFI. Early bounces that still need to prove themselves.

• Cooled out of Trend-Hold into Transitional: COPX, FFIV. Leaders that lost their trend and now need to re-prove it.

• ·Lost the trend, into Repair: FTI. Downgraded a full step, treat as damaged until reclaimed.

• Broke down: COST, LMT, NVO, WMT, XOM. Fresh damage, the framework moves these to the avoid list.

• Biggest movers: NBIS +23%, CRWV +17%, TSM +9%, AMAT +9% to the upside; FTI -8%, XOM -6%, LULU -6%, LMT -5% to the downside.

How Our Trade Plans Work

Our framework is rules-based and level-driven. We classify each name into a regime (Trend-Hold, Transitional, Repair, or Breakdown) using the 1D EMA stack, cross-checked against the 1W chart. Every entry, target, and invalidation traces back to a specific indicator level.

T1 is the first profit-take layer, T2 is the structural objective, T3 is the stretch target on full continuation. Sizing follows the regime: Trend-Hold names take normal size but only on a pullback to support or a confirmed breakout; Transitional names take half size or wait; Repair names take a starter only after a reclaim; Breakdown names are avoided until a reclaim confirms.

Two stops, two jobs. The trade stop protects the position; the regime invalidation changes the thesis. The trade stop is the tactical level where a single trade is wrong and you cut it. The regime invalidation is the deeper level where the entire classification flips to a lower regime and the reason to own the name is gone. They differ on purpose: one manages risk, the other manages conviction.

Cash is a position, and waiting is part of the plan. This update ranks 60 stocks and ETFs: the highest-conviction, near-entry names get a full setup, and the rest are tracked in the watchlist table so nothing in the universe goes uncovered.

This Week’s Playbook

Start here. The detailed setups follow for the top names, and the full watchlist table covers the rest.

• Best risk/reward this week: LLY, GOOG, NVDA, RBRK, SPY, UNH (+5 more in the table). Price is already at a defined entry on the 1D EMA20, so the trigger is near and the risk is tight; these are the names that reclaimed or held their trend, the cleanest longs to engage as leadership rotates.

• Best leaders to buy only on weakness: OSCR, ASML, INTC, LRCX, NBIS, SMSN.L. Clean trends with room to run, but buy the pullback, do not pay up here.

• Most dangerous chase setups: AMAT. Overbought leaders; the trend is real but the entry is not, wait for a reset.

• Avoid until a reclaim confirms: ADBE, BABA, BIDU, COST, ETHA, GLD, INTU, LMT, LULU, META, MSFT, NFLX, NOC, NVO, PALL, PINS, PLTR, SHOP, SLV, WMT, XOM, XRH0.L, XRPI. No long exposure; not every dip is a setup, and cash is the position.

This update covers the following 60 stocks and ETFs across consumer, technology, healthcare, industrials, and commodities.

Top 5 Actionable Setups

The highest-conviction names sitting closest to a defined entry, with full detail, levels, and both stops for each. The next tier follows in the Also Actionable table, and the rest of the universe in the full watchlist below it.

Read more

The catch is the math. ASTS carries a market value in the tens of billions of dollars on under $100 million of sales, hundreds of times over. This isn’t a normal stock you value on earnings. It’s a venture bet that happens to trade on a public exchange.

Key Takeaways

• What it is: ASTS is building a constellation of satellites that connect directly to ordinary, unmodified smartphones, sold wholesale through carriers. It says it has agreements with close to 60 operators covering more than 3 billion subscribers, including AT&T, Verizon, and Vodafone.

• The catalyst: it just launched BlueBird satellites 8, 9, and 10 on a SpaceX rocket, and a roughly $1 billion Japanese direct-to-cell award, with an ASTS-Rakuten alliance seen by investors as a credible contender, is expected to be decided by month-end.

• The catch: investors are paying hundreds of times trailing sales for a business whose commercial service has barely begun, and it’s burning above $1 billion a year in cash. Even hitting this year’s $150 to $200 million revenue goal would leave the stock well over 100 times sales.

• The setup: after running to $134 and crashing to the low $80s, the stock sits right on its 200-day average, with analysts split, mostly holds, and an average target near $81, almost exactly where it trades.

Start with what the company is actually building.

The Moonshot

The pitch is audacious. Most satellite phone services need a bulky special device and a clear view of the sky. ASTS wants to skip all that and talk directly to the handset you already own, filling the dead zones where cell towers don’t reach, on land, at sea, in the middle of nowhere. Think of each satellite as a cell tower in space, big enough to connect to a standard phone hundreds of miles below.

It doesn’t sell to you, though. ASTS runs a wholesale business: it builds and operates the satellites, and your existing carrier rents the capacity to extend its own coverage. That’s why the partner list reads like a who’s-who of telecom, AT&T, Verizon, Vodafone, Rakuten, Google, and Saudi Arabia’s stc among them, with agreements spanning close to 60 operators and more than 3 billion subscribers worldwide.

The satellites are called BlueBirds, and the entire thesis comes down to a single question: can ASTS get enough of them into orbit, working, to deliver steady coverage before it runs out of money? Management says it needs roughly 45 to 60 satellites for continuous service across the United States, a milestone management is targeting this year.

Why Now: A Launch and a Japan Decision

A pair of developments put ASTS back in the headlines this month. First, the launches. A SpaceX Falcon 9 carried the next trio of BlueBird satellites, numbers 8, 9, and 10, into orbit, and management says these are more capable craft that should nearly double the network’s peak data speeds. Every successful launch is a piece of proof that the plan is real and roughly on schedule, which is why the stock jumped on the news. But a clean launch is a milestone, not commercial proof. The next test is whether those satellites unfold, pass their checkouts, slot into the network, and start turning into recurring carrier revenue.

Second, a decision out of Japan. The country is picking a partner for a roughly $1 billion program to build a domestic direct-to-cell satellite network, and an alliance between ASTS and Rakuten is seen by investors as a credible contender, up against a consortium built around SpaceX. A win would be a marquee validation and a real, named revenue source; a loss would sting. A decision is expected by the end of June, which is part of why the stock has been so jumpy.

What the Numbers Say

Here’s where ASTS stops behaving like a normal stock. It took in only about $85 million of revenue over the past year, roughly $71 million of that in 2025, a mix of gateway-equipment sales and government contracts rather than a steady stream of paying users, because the commercial network barely exists yet.

Against that, the company is worth somewhere between $23 billion on its quoted market cap and about $31 billion counting all its share classes. Either way, investors are paying hundreds of times trailing sales, where an expensive software company might trade at 15 or 20 times.

Management guides to $150 to $200 million in revenue this year, which would more than double 2025, but even the top of that range leaves the stock well over 100 times sales. And there are no profits to value: ASTS is deeply unprofitable, with free cash flow running to around negative $1.4 billion over the past year, driven largely by the capital cost of building and launching its fleet.

So you can’t analyze this the way you’d analyze a bank or a retailer. The figures that matter aren’t margins or multiples; they’re the ones that decide whether ASTS reaches the finish line before the cash runs out. It holds more than $3 billion in cash against a similar pile of debt, enough to fund a couple of years at the current pace, and management has said its capital should carry it toward that 45-to-60-satellite coverage threshold. But more satellites mean more rockets, and more rockets usually mean more share sales, so dilution is a steady tax on anyone who owns it.

On the other side of the ledger, the commercial traction is real, not vapor: a formal agreement with Verizon to carry the service this year, and a 10-year deal with stc that came with a $175 million upfront prepayment, on top of more than a billion dollars of commitments already signed. The bull case is that those contracts turn into billions in high-margin wholesale revenue once the network is live.

The bear case is that “once the network is live” is doing an enormous amount of work in that sentence. Wall Street is openly split: the average price target sits near $81, almost exactly where the stock trades, and most analysts rate it a hold, with a few outright sells. For a name this beloved by retail investors, that’s a cool reception from the professionals.

Give the bulls their due: this isn’t a consumer-subscriber ramp from zero. ASTS already has the carrier relationships, the signed commitments, the upfront cash, and a wholesale model that could scale fast if the constellation comes together. That’s a real foundation, and it’s why the believers tolerate the price. The problem is that “if” still carries most of the valuation.

The Technical Picture

The tape is a parabola that broke. ASTS ran to nearly $134 in late May, then fell hard, and at $80.66 it’s about 40% off that peak, below its 20-day and 50-day averages (both around $91) and sitting right on its 200-day near $79. That 200-day is the line that matters: hold it and the longer uptrend is intact; lose it and the next real support is far below. Momentum is soft but not yet washed out.

And the swings are violent: the stock moves more than 13% on an average day. With a name like this, position size matters far more than entry precision.

Here’s how I’m reading the levels.

Levels We’re Watching

This is a binary, milestone-driven stock, not a value one. Treat any position as a venture bet and size it for violent swings. These are levels to watch, not instructions.

Read more

SoFi Technologies has quietly pulled off one of the harder turns in finance: it stopped being a money-losing student-loan refinancer and became a profitable, fast-growing digital bank. The latest quarter was a record, with net revenue up 43% and profit more than doubling. It just launched the first stablecoin issued by a US national bank, and it handed everyday investors a way into the SpaceX listing, the largest IPO ever. And yet the stock, at $17.91, still sits about 45% below its high near $33 and below its own 200-day average. The market clearly likes the story. It just can’t decide what to pay for it.

Key Takeaways

• SoFi is now a profitable bank growing fast. The March quarter set records: net revenue of $1.1 billion, up 43%, net income of $167 million, more than double a year earlier, and membership up 35% to 14.7 million.

• The buzz is in the new businesses. SoFiUSD is the first stablecoin from a US national bank to live inside a consumer banking app, and SoFi was one of only a handful of brokerages to give retail investors allocation in the record SpaceX IPO.

• The catch is valuation, not the business. Reported per-share earnings were flat last fiscal year, skewed by a one-time tax benefit in the prior-year base, and at 40 times earnings the stock already prices in a lot of future growth.

• At $17.91 the stock trades near 40 times trailing earnings and almost 6 times sales, below the $20.90 average analyst target but rated only a hold, with one firm just cutting to $17.

Start with the company that exists today.

From Refinancer to Bank

SoFi began as a way to refinance student loans and spent years losing money chasing growth. The turn came when it bought a small bank and won a national bank charter, which let it hold customer deposits instead of borrowing expensively to fund its loans. Cheap deposits changed the math. SoFi now operates across lending (personal, student, and home loans), financial services (checking, savings, brokerage, a credit card), and Galileo, the business-to-business engine that quietly powers other companies’ banking apps.

The most recent quarter showed how far the turn has come. Net revenue hit a record $1.1 billion, up 43% from a year earlier and ahead of what Wall Street expected. Net income reached $167 million, more than double the year before. Adjusted earnings before interest, taxes, depreciation, and amortization, a rough cash-profit gauge, rose 62% to a record $340 million. Loan originations hit a record $12.2 billion, members grew 35% to 14.7 million, and the products those members use climbed 39% to 22.2 million. SoFi also raised its outlook for the year. This isn’t a company hoping to work. It’s one that’s working.

The New Story: Crypto Rails and IPO Access

What’s been pushing the stock around lately isn’t the lending bank, though. It’s the new stuff. In late May, SoFi launched SoFiUSD, a stablecoin, which is a digital token pegged 1-to-1 to the US dollar and redeemable for real dollars through SoFi Bank.

It’s the first stablecoin issued by a US national bank to live directly inside a consumer banking app, available to nearly 15 million members and running on the Ethereum and Solana networks.

The pitch is that SoFi can move money faster and cheaper than the old rails, earn a spread on the reserves backing the token, and eventually sell that infrastructure to other banks and companies. It’s early, though, and worth being clear-eyed about: a SoFiUSD balance is a regulated crypto product, not an insured bank deposit, so it doesn’t carry the FDIC protection that sits behind SoFi’s savings accounts.

Then, in mid-June, SoFi was one of only a handful of brokerages chosen to hand retail investors actual allocation in the SpaceX listing, the largest IPO on record at more than $75 billion raised, letting members buy at the offering price instead of chasing the stock after it opened.

For a generation of users locked out of hot offerings, that’s a real draw, and it leans into SoFi’s pitch of being the one app for your whole financial life. None of these are big revenue lines yet. They’re option value, a wager that SoFi becomes a fintech that does everything, not just a bank that lends. The chief executive seems to believe it: he’s bought his own stock several times this year.

There’s a hole in that story, though, and it widened this quarter. Galileo, the technology business meant to prove SoFi is more than a lender, saw its revenue drop 27% from a year earlier, with segment profit down even harder, after it lost Chime, a big client that moved off its rails.

SoFi has signed new customers to fill the gap, but the timing stings: the premium on the stock leans on the idea that technology and infrastructure become a second engine, and right now lending is doing the heavy lifting while that engine sputters.

What the Numbers Say

Set the growth next to the price and the tension jumps out. Revenue is compounding fast, up 42% over the past year, 38% last fiscal year, and roughly 32% a year over 3 years. The bank is genuinely profitable, with a 15% net margin and an 18% operating margin, and debt is low for a lender.

Reported earnings per share look flat, near $0.39, the same as a year earlier, but that flat line hides real progress. The 2024 figure was padded by a one-time $258 million tax benefit, so on an adjusted basis SoFi earned just $0.15 that year. Strip the windfall out and underlying per-share profit rose sharply in 2025. The growth is real; the reported headline just masks it.

That’s why the valuation is the whole debate. At $17.91 the stock trades near 40 times trailing earnings and almost 6 times sales, rich for a bank, even a fast-growing one. The forward multiple drops to about 22 times, which tells you the market expects earnings to jump as the loan book matures and the new businesses scale. If that lands, today’s price looks reasonable. If growth cools or credit costs rise, 40 times earnings is a long way to fall. Return on equity is still under 7%, a reminder that for all the growth, SoFi isn’t yet the profit machine its multiple implies.

What’s Moving the Stock

There’s no single event behind the recent action. It’s a tug-of-war. On one side, the stablecoin launch and the SpaceX access have pulled traders back to the name, and the chief executive’s repeated buying adds a vote of confidence. On the other, the analysts who cover it aren’t convinced: the average rating is a hold, and Truist just trimmed its target to $17, below today’s price, on softer near-term expectations for the lending and technology businesses. Buyers and sellers have fought it to a standstill below $20.

The Technical Picture

The tape says recovery, not breakout. After bottoming near $15, SoFi has climbed back to $17.91, now above its 20-day and 50-day averages, both near $17, but still below its 200-day average at $19.62, the level bulls need to reclaim. Its daily relative strength index, a 0-to-100 momentum gauge where over 70 is overbought, sits at a neutral 58, with room before it runs hot.

The trend-strength reading (ADX) is low, near 19, which says this is choppy, range-bound trade rather than a powerful move. In plain terms, SoFi has stabilized and is grinding higher, but it hasn’t proven much yet. The $20 area, where the 200-day, the round number, and the average analyst target all cluster, is the line that matters.

Here’s how I’m reading the levels.

Levels I’m Watching

This is a high-beta, story-driven stock: a 2.15 beta means it swings more than twice as hard as the market, so size any position for the volatility. These are levels to watch, not instructions.

• Pullback support: $16 to $17, the 20-day and 50-day averages and the base this rally was built on.

• Breakout: a close above $20 reclaims the 200-day average and clears the round number, opening the path toward the $21 analyst target and beyond.

• Caution line: $15 is the line in the sand. Lose it while credit metrics weaken, and the setup flips from base-building to failed recovery.

• Targets on a breakout: $21, then $26 and $31, the last back near the Street-high target and the old high near $33.

• The real test is the next earnings report, and whether the new businesses start showing up in revenue while the loan book keeps growing without credit cracking.

Bottom Line

SoFi has earned its re-rating: it’s profitable, growing fast, and building real optionality in crypto rails and capital markets. But at 40 times earnings, with return on equity in single digits and its technology engine stalling just as the story needs it to fire, the price assumes execution it hasn’t delivered yet. Here’s where I come down. At $18, below the 200-day and below where analysts value it, this isn’t a chase. The better setup is patience: add on a clean reclaim of $20, or down near the $15 base, and watch one number above the rest, whether the technology business turns back up. Get that, and the premium is earned. Miss it, and SoFi is a fast-growing lender wearing a fintech multiple.

This is research and commentary, not personal investment advice. Levels are illustrative; size positions to your own risk tolerance and time horizon. The author may hold positions in names discussed.

Key Takeaways

• HIMS closed at $35.47 after Barclays raised its target to $39, the top of the analyst range. The stock has more than doubled off its 52-week low of $13.74, though it’s still about half its $70.43 high.

• The comeback rests on weight-loss drugs. After regulators forced Hims off cheap copycat versions of Ozempic, it struck a deal with Novo Nordisk to sell the branded drugs directly, and early demand has been strong.

• Growth went sideways in the meantime. Revenue rose just 4% in the March quarter against 59% for all of 2025, and the company is guiding to a sharp re-acceleration in the back half of this year.

• The price has run ahead of the analysts. At $35.47 the stock sits above the $27.32 average target and trades near 40 times forward earnings, with a market value around $8 billion and a beta of 2.4, more than twice as volatile as the market.

Start with how a $70 stock became a $14 stock.

The Comeback

Hims & Hers is an online health company. You sign up through its app, get a consult, and have prescriptions and products shipped to your door, originally for hair loss, skin, and men’s health, and more recently for mental health and weight loss. The model is sticky and high-margin: most of it is recurring subscriptions, and for years the gross margin ran above 70%.

Then the weight-loss craze arrived, and Hims rode it harder than anyone. The blockbuster drugs, Novo Nordisk’s Ozempic and Wegovy, were in such short supply that pharmacies were able to sell compounded semaglutide products tied to the same active ingredient, often at far lower prices than the branded drugs. Hims sold those compounded versions at scale. Revenue rose 59% in 2025 to $2.35 billion, the company turned a profit, and the stock ran to about $70 as investors treated it as the cheap on-ramp to the biggest drug story in a decade.

The unwind was just as fast. Regulators declared the shortage over, which removed the legal basis for mass-compounding the drug. Hims had to wind down its compounded weight-loss line, the very thing that had powered the run. Growth fell off a cliff, the bears called the whole weight-loss engine a mirage, and the stock collapsed to $13.74. What the rules gave, the rules took away.

The current bounce is the second act. In March, Hims signed a deal with Novo Nordisk to offer branded Wegovy through an authorized channel, swapping the compounded versions for the genuine article. The early traction has been quick: within 6 weeks of switching it on, the company says it fulfilled more than 125,000 Wegovy shipments. It raised full-year revenue guidance to a range of $2.8 billion to $3 billion, which would be growth of 19% to 28% over 2025. And there’s more in the pipeline, a separate brand opening pre-orders for Novo’s Wegovy pill in Britain, and a regulatory hearing next month on whether to add 7 peptides to an approved list, which could open another product line if it goes Hims’ way.

That’s the story Barclays bought yesterday. The trouble is that buying the story now means paying for the part that hasn’t happened yet.

What the Numbers Say

Strip out the narrative and the recent results are a study in transition. Over the trailing year revenue is about $2.37 billion, but the company is now barely breakeven on the bottom line, a slight net loss, after being solidly profitable a year ago. The March quarter is where you see the cost of the pivot most clearly: revenue of $608 million, up just 4% from a year earlier, with a net loss of about $92 million against a $49.5 million profit in the same quarter last year. Gross margin fell to 65% from 73%. That drop isn’t an accident. Reselling someone else’s branded drug is a far lower-margin business than mixing your own copy or selling your own subscriptions, so the comeback is being bought partly with profitability.

That’s the central tension. The bull case needs the guided second-half re-acceleration, full-year growth climbing from last quarter’s 4% back toward 20% or more, without margins eroding further as branded drugs take a bigger share of the mix. More Wegovy sales mean more revenue and thinner margins at once.

On valuation, the stock isn’t cheap on any normal measure. There are no trailing earnings to speak of, so the price-to-earnings ratio is meaningless on a backward look. On forward estimates it trades near 40 times earnings, and at roughly 3.5 times trailing sales, under 3 times next year’s guided sales. For a company guiding to 20%-plus growth with strong gross margins, that’s defensible, not absurd, but it’s a growth price that assumes the growth shows up. And the people paid to value it aren’t there yet: the average analyst target sits at $27.32, well below yesterday’s $35.47 close, and Barclays’ new $39 is the high end of the range, not the consensus. When a stock trades above the average target, the market is betting the analysts are about to chase it higher. Sometimes they do. Sometimes the stock comes back to them.

One more number frames its personality. The beta is 2.4, and the daily range averages more than 6% of the price. This is a stock that can move 10% on a headline in either direction, which cuts both ways: it’s why it more than doubled off the low, and it’s why it fell 80% before that.

What Happened Yesterday

There was no earnings report and no company announcement behind the move. It was an analyst re-rating: Barclays lifted its target to $39 from $29 and reiterated “overweight,” arguing that strong weight-loss demand plus the Novo deal will drive a sharp acceleration in revenue and in EBITDA, a rough proxy for cash profit, in the second half. The firm pointed to its own read on the data, website traffic up 12% year-over-year in April and 35% in May, and card transactions up 16% month-over-month, and called the Novo partnership a “clear inflection.” A steady-rates backdrop from the Fed helped the mood, but read the day for what it was: not a new fact about the business, just a credible voice raising its hand on a stock that was already running. Momentum like that can keep working, but it’s sentiment confirming a trend, not proof the trend will hold.

The Technical Picture

The tape says the same thing the valuation does: powerful, and stretched. At $35.47, HIMS sits far above all its major moving averages, its 20-day near $28.60, its 50-day near $26.73, and its 200-day near $30.59, which puts the price roughly 24% above its own 20-day line. That’s the signature of a vertical move, not a steady climb. Its daily relative strength index, a 0-to-100 momentum gauge where over 70 is overbought, has pushed to 71, and the shorter intraday readings are hotter still, in the high 70s. The trend-strength reading (ADX) sits at 23, which says a real trend is building but isn’t yet extreme.

There’s one encouraging wrinkle. On the weekly view the same momentum gauge is only at 59, not overbought, which leaves room on the bigger picture if the stock can consolidate rather than reverse. The clean read: HIMS has broken out above the $30 area that capped it for weeks, but it’s done so in a hurry and is overbought short-term. Breakouts like this usually need to digest, and the most common way to do that is a pullback toward the breakout level before the next attempt.

Here’s how I’m reading the levels.

Levels We’re Watching

This is a high-beta, story-and-regulation stock, not a value one. Treat any position as a bet on the weight-loss re-acceleration landing, and size it for the swings. These are levels to watch, not instructions.

• Pullback support: $29 to $32, the breakout area around the old $30 ceiling and the rising 20-day average, where a stretched move tends to find its footing.

• Breakout: a push above $36, just over yesterday’s close, would say the momentum has more to give and open the path toward $39, the Barclays target and the top of the analyst range.

• Caution line: a close back below $27, the 50-day average and the top of the prior range, would say the breakout failed and the stock is back where it started.

• Targets on continuation: $39, then $44 and $50. Size for the volatility, because a name with a 2.4 beta can hand back a week of gains in a single session.

• The real test isn’t a level. It’s the regulatory hearing next month and the next earnings report, where the promised back-half acceleration has to actually show up in the revenue line.

Bottom Line

Hims & Hers has earned its second act. The Novo deal gives the weight-loss business a cleaner foundation, the early demand looks real, and Barclays may be right that the second half inflects. But at $35, investors aren’t being paid for disbelief anymore. They’re paying for execution: faster growth, margins that hold, and no fresh regulatory surprise. The comeback is believable. The question is whether the easy part of the trade has already happened.

This is research and commentary, not personal investment advice. Levels are illustrative; size positions to your own risk tolerance and time horizon. The author may hold positions in names discussed.

Tesla is the most divided stock in the market, and right now it’s eerily quiet, coiling near $396, sitting right on its 200-day average and going nowhere. That calm hides a strange split. As a car company, Tesla is a thin-margin, modestly-growing manufacturer: revenue up about 16% over the past year, but an operating margin of 5% and a net margin under 4%. Yet it trades at nearly 380 times earnings and about $1.5 trillion, because the market long ago stopped pricing the cars. It’s pricing robotaxis and humanoid robots. The next tests are dated, Q2 deliveries in early July and earnings on July 22.

Key Takeaways

• Tesla’s valuation is no longer about EVs. At about $1.5 trillion and nearly 380 times earnings, the price lives in autonomy, robotaxis, and Optimus, not in cars.

• The car business throws off real cash, about $7B last year, but at a 5% operating margin and mid-teens growth it can’t justify that valuation on its own.

• The robotics and autonomy story is becoming more tangible, robotaxis in Texas, FSD on subscription, a capex pivot toward Optimus, but it isn’t scaled enough yet to carry the multiple.

• The stock is coiled near its 200-day ahead of Q2 deliveries (early July) and July 22 earnings, a low-volatility base waiting for a catalyst.

Start with the company that actually exists today.

The Car Company

Tesla still builds more electric vehicles than anyone and still throws off real cash, about $7B of free cash flow over the past year on $97.88B of revenue. But the car business has cooled. Growth has slowed to the mid-teens, and margins have been squeezed by price cuts and a wall of new competition: a 19% gross margin, a 5% operating margin, and a sub-4% net margin, with the March quarter earning just $0.13 a share on a reported basis ($0.41 adjusted). Demand has shifted too, from supply-constrained, with buyers once on waitlists, to a company that now has to coax sales with price cuts and cheap financing, while BYD outsells it globally and every legacy automaker ships credible EVs. The long-promised cheaper, mass-market model keeps slipping. The one clean near-term positive is volume: Q2 deliveries, due in early July, are expected around 420,000, a beat versus consensus near 400,000. But even a strong quarter doesn’t change the core math, more cars at thin margins is a bigger low-margin business, not a different kind of company. The brighter spot the bears underrate is energy: Tesla’s battery-storage arm is growing fast and at better margins than the cars, a real if smaller second engine, and the kind of high-quality profit the vehicle side increasingly needs.

None of that is fatal. Tesla is still the most profitable pure EV maker and still generates cash. But it’s a maturing carmaker now, not a hypergrowth one, and it’s priced like no other automaker on earth. At roughly 15 times sales and nearly 380 times earnings, it trades at multiples Ford and GM can only dream of, both sit at single-digit earnings multiples and a fraction of their sales. Value Tesla as the car company it is today and the market implies only about $200 a share is the automaker. Strip out autonomy and robotics, and the auto business alone cannot carry the current valuation.

Now the part the price is actually about.

The Robot Bet

That other roughly $200 a share is the future Elon Musk keeps promising, and it’s slowly becoming more than a promise. Tesla’s robotaxi service has rolled out in Austin and, by reports, expanded into Dallas and Houston, though at still-limited scale and with longer wait times than some analysts expected. Its FSD driver-assistance software has moved to a subscription, with adoption reportedly climbing. And the loudest signal of intent: Tesla is reportedly preparing to wind down the Model S and Model X to free factory space for Optimus, its humanoid robot, with a roughly $25 billion capital plan tilting away from cars toward AI and robotics.

The bull logic is straightforward. A robotaxi network earns software-like margins, not the 19% gross margin of a car, so a fleet that scales could eventually be worth more than the entire vehicle business. A subscription turns a one-time sale into recurring revenue. And Optimus, if it ever ships at volume, addresses a market Musk describes in the trillions. Bulls also point to the operating leverage: the FSD software that would power a robotaxi is the same code Tesla already ships in millions of cars, so once the technology clears its safety bar, the marginal cost of each autonomous mile could be low. Stack those up and you can squint your way to numbers that dwarf today’s price. That case isn’t crazy.

But each leg carries real risk. Robotaxis answer to regulators and a safety bar where one bad incident becomes a national headline, and Waymo is already further along in genuinely driverless miles. Optimus is still a demo becoming a product, a hard and unproven leap. The cost is real, too: building robots, training the models, and standing up a fleet runs into the tens of billions, pressuring the very free cash flow the bulls expect it to compound. And it all rests heavily on one person, whose attention is split across Tesla, SpaceX, xAI, and more, even as he keeps tightening his grip by converting options into voting shares. Autonomy has been just around the corner for a decade. The technology is real and improving, but the multiple doesn’t only need it to work, it needs it to scale, and fast. Every quarter the robots stay small, the thin-margin car business has to carry a trillion-dollar-plus valuation by itself, and it can’t. The July report is the first real referendum: scaling robotaxi rides, compounding FSD revenue, or a credible Optimus timeline would justify the premium, while another quarter of small autonomy numbers against thin car margins makes the multiple the problem rather than the promise.

The tape, for now, is holding its breath.

The Technical Picture

Tesla is coiling. At $396 it sits right on its 200-day average near $397, just under its 20-day ($408) and 50-day ($406), with the daily relative strength index, a 0-to-100 momentum gauge, at a neutral 45 and the trend-strength reading (ADX) down at 17, which signals no trend at all, just chop. The stock has spent weeks oscillating in a $337-to-$491 band and now sits dead in the middle. This is a coiled spring: a quiet, low-volatility base. The longer this range holds, the more important the eventual break becomes, and the catalysts are already on the calendar, Q2 deliveries in early July and earnings on July 22.

Here’s how I’m reading the levels.

Levels We’re Watching

This is a high-variance, story-driven stock, not a value one. Treat any position as a call option on autonomy, and size it that way. These are levels to watch, not instructions.

• Accumulation zone: $360 to $385, the lower half of the range, where buyers have repeatedly stepped in.

• Breakout: a push above $432 clears the 50-day and the mid-range resistance, opening the path toward the $460 to $491 range high.

• Caution line: a close below $335, the range floor, would break the structure and put the car-company-only valuation back in focus.

• Targets on a breakout: $460 (the median analyst target), then $491 and $520. Size for the swings, because a stock at this multiple can move 10% on a single delivery number.

• The real test is dated: Q2 deliveries in early July and earnings on July 22, plus any step-up in robotaxi scaling.

Bottom Line

Tesla at $396 isn’t a bet on today’s earnings. It’s a bet that robotaxis and Optimus become real businesses soon enough to justify today’s valuation. If they scale, the premium can survive, and might even look cheap. If they stay small, the auto business has to carry the weight, and the math gets much harder. The question isn’t whether Tesla is still a car company. It’s whether the robots arrive on Musk’s timeline, or on a much slower one.

This is research and commentary, not personal investment advice. Levels are illustrative; size positions to your own risk tolerance and time horizon. The author may hold positions in names discussed.

Intel is the comeback story of the cycle. The stock has gained more than 400% over the past year, peaking near $133 last week, as investors bet that its long, painful turnaround, new advanced manufacturing, a revived foundry, and AI-driven chip demand, is finally working. Then yesterday it fell about 8.5%, from $127.86 to $117.05. There was no disaster behind it: no bad earnings (the next report is July 23), no guidance cut, no scandal. It was profit-taking in a stretched stock on a weak day for tech, against a louder competitive backdrop. The drop didn’t break the trend. But it’s a useful reminder of what the rally has glossed over: the numbers haven’t caught up to the story.

Key Takeaways

• Intel has gained more than 400% in a year on turnaround optimism: its 18A process is moving through production milestones, and AI is reviving demand for its processors. The narrative is genuinely improving.

• But it’s still losing money on a GAAP basis: a $3.7B net loss in the March quarter, the foundry alone down $2.4B, even as adjusted earnings just squeaked positive. It’s also burning cash to build fabs.

• The valuation has run far ahead of the business. At $117 the stock trades around 10 times sales and an extreme multiple of the slim profits analysts expect, with no trailing GAAP earnings at all.

• Wall Street doesn’t buy the price. The average analyst target sits around $90, roughly 20% below where the stock trades, and the rating is a hold.

• Yesterday’s 8.5% drop was profit-taking, not a fundamental break. Intel still sits above all its major moving averages, so the uptrend is intact, just stretched.

Start with why the stock ran so far.

The Comeback Story

For years Intel was the cautionary tale of American technology: it lost the manufacturing lead to TSMC, missed mobile, missed AI accelerators, and watched AMD eat its market share. The turnaround bet is that this is reversing. Its most advanced process, 18A and the 18A-P variant, is moving through production milestones, the first time in years Intel’s manufacturing has looked competitive with TSMC’s leading edge. Its foundry arm, the contract-manufacturing model that minted TSMC, is chasing external customers. AI is refreshing demand for the PC and data-center processors Intel still serves. And Washington’s drive to reshore advanced chipmaking hands it a strategic tailwind few companies enjoy. That story, more than any single quarter, is what took the stock up more than 400%.

It isn’t pure hope, either. The real validation is still ahead, external customers buying 18A at volume, with competitive yields and margins, but if that lands, the whole thesis confirms at once, and today’s losses read as the investment phase of a much larger franchise. That’s the prize the rally is reaching for.

The trouble is what the story still costs.

But the Numbers Haven’t Caught Up

Strip away the narrative and the financials are sobering. In the March quarter Intel lost about $3.7B on a GAAP basis, the foundry alone accounting for $2.4B of it, even as adjusted, non-GAAP earnings squeaked to a small profit of about $0.29 a share. Management guided the current quarter to roughly breakeven on a reported basis and a modest adjusted profit, the inflection bulls point to. But step back to the trailing year and Intel still generated roughly $54B of revenue at a net loss, with a negative return on equity, while burning cash to pour tens of billions into new fabs. On a reported basis, there are no trailing earnings to value it on at all.

On the measures that do work, it’s expensive. The stock trades around 10 times its sales, rich for a low-margin manufacturer that isn’t reliably profitable, and at an extreme multiple of the modest forward profits analysts expect, with estimates running from the 70s to well over 100 times earnings, all of them steep. Its market value is more than half a trillion dollars. And the people paid to value it aren’t convinced: the average analyst target sits around $90, roughly 20% below the current price, the rating is a hold, and one widely-followed fair-value model pegs it far lower still. In plain terms, the stock is priced as if the turnaround is already finished. It’s barely begun.

The bull’s fair counter is that turnarounds are always priced on the future, not the past, and that the foundry losses are deliberate, the cost of building capacity that swings to profit as the fabs fill. That’s true, and it can run a long way: if utilization keeps climbing, the losses keep narrowing, external customers commit real volume, and AI keeps refreshing the PC and data-center cycle, Intel can stay expensive far longer than the financials alone would justify. Momentum names usually do. The question is degree. At 10 times sales, no GAAP profit yet, and the stock 20% above what analysts think it’s worth, the market isn’t just betting the turnaround works, it’s betting it works quickly and cleanly, with little room for the stumbles that have defined Intel’s last decade.

What Happened Yesterday

The 8.5% drop had no single smoking gun: no earnings miss, no guidance cut, no scandal. A few things lined up instead. It was a stretched stock taking a breather on a weak day for tech, with the Nasdaq down more than 1%. After a 400%-plus run, a pullback like this is the kind of air pocket momentum names hit regularly. And in the background, Nvidia’s push into AI-focused PC chips, aimed at the personal-computer processor market Intel still leads, added to the competitive pressure, a reminder that even Intel’s strongholds are contested. None of it changes the long-term thesis. Together they gave a crowded, extended trade an excuse to take profits. See the move for what it was: a stock that had nearly tripled from its April low, shedding 8% in a jittery tape as the competitive backdrop got louder. Extended winners don’t need much of a reason. What matters now is whether the dip-buyers who powered this run keep showing up.

The Technical Picture

For all the drama, the drop barely dented the uptrend. Intel still trades above its 20-day average near $113, its 50-day near $99, and its 200-day near $63, the last of which shows just how far and fast this has run. Its daily relative strength index, a 0-to-100 momentum gauge where over 70 is overheated, sits at a neutral 55 after the pullback, while the weekly reading is hotter at 67. The drop pulled price right back to the rising 20-day line, the first test of whether buyers still step in. As long as that area holds, this is a pause in an uptrend, not the start of a reversal.

How to Position

This is a momentum-and-story stock, not a value one, so treat it that way. These are levels to watch, not instructions.

• Pullback support: $105 to $114, the rising 20-day average and the early-June base, where a stretched uptrend tends to find its footing.

• Breakout: a reclaim of the $133 high would say the momentum has resumed.

• Caution line: a close below $98, the 50-day average, would break the near-term uptrend and warn the air pocket is turning into something bigger.

• Targets on continuation: $145, then $160 and $175. Size for the swings, because a stock up 400% can give it back fast.

• The real test isn’t a level, it’s the July 23 earnings report. Evidence the foundry losses are narrowing and external traction is building would justify the price. Another quarter of deep losses would make $117 hard to defend.

Bottom Line

Intel’s comeback is real, and that’s exactly why it’s dangerous here. The 18A progress, the foundry traction, the AI demand, all genuine. But a stock up more than 400% in a year, still posting GAAP losses, burning cash, and trading 20% above what analysts think it’s worth has already banked the win in advance. Yesterday’s drop didn’t break anything; it just showed how little cushion is left.

One number frames it: Intel is worth more than half a trillion dollars today, on a business that lost $3.7B in the March quarter alone. The market is paying for the Intel that might exist in 2028. Whether you want to own it comes down to whether you believe that Intel arrives, and on a name this stretched, the cheaper moment to ask usually comes after the next pullback, not before it.

Share

This is research and commentary, not personal investment advice. Levels are illustrative; size positions to your own risk tolerance and time horizon. The author may hold positions in names discussed.

Oil is high? Fine, earnings can absorb it.

Big tech is spending too much? Fine, AI is the future.

IPO activity is heating up? Fine, that means risk appetite is alive.

Midterm year volatility? Fine, politics is noise.

Inflation is sticky again? Fine, the Fed can look through energy.

The problem is not any one of these things by itself.

The problem is when they all show up at the same dinner table, order the most expensive wine, and hand the bill to equity investors.

That is where I think we are today.

This is not a “sell everything and hide under the mattress” argument. That is usually bad investing and worse writing. The market is not obligated to collapse just because risks are building. Expensive markets can become more expensive. Momentum can keep working. AI can be real. Big tech can remain dominant. Oil can cool. Inflation can settle. Elections can pass.

But risk is not about certainty.

Risk is about the price you are paying for the range of outcomes in front of you.

Right now, the market is paying a very full price for a very narrow version of the future.

That is the issue.

The S&P 500 has recently been making repeated all-time highs. The AI trade remains crowded. Big tech is still the center of gravity. Investors are still behaving as if the largest companies in the index can spend like utilities, grow like software monopolies, trade like safe havens, and still deserve premium multiples.

Maybe they can.

But that is a lot to ask at the same time oil is pressuring inflation, the Fed has less flexibility, IPO supply is returning, AI infrastructure spending is exploding, and a midterm election year is starting to raise the political temperature.

One risk can be noise.

Five risks arriving together after an all-time high is not noise.

That is a setup.

The market is not priced for “fine”

Markets can handle bad news. They do it all the time.

What markets struggle with is bad news after perfect pricing.

When stocks are cheap, hated, and under-owned, bad news can be absorbed. Expectations are low. Cash is high. Positioning is defensive. Valuations already carry some fear.

That is not this setup.

This setup is closer to the opposite.

The market has been rewarding growth, rewarding AI exposure, rewarding scale, rewarding anything that can plausibly be tied to the next decade of computing demand. Big tech has carried the index. The largest companies have become the market’s safe haven, growth engine, bond alternative, AI proxy, and liquidity sink all at once.

That works beautifully on the way up.

It becomes fragile when the story changes from “these companies print cash” to “these companies need to spend cash at a pace we have never seen before.”

That is the quiet shift happening now.

For years, the best technology companies were loved because they were capital-light. They scaled software, ads, subscriptions, cloud, marketplaces, and networks. The beauty of the model was simple: once the platform was built, incremental revenue could be extremely profitable.

AI infrastructure is different.

AI is not just code. It is chips, power, cooling, land, data centers, transmission, financing, depreciation, and constant upgrades.

In other words, the market is still valuing many of these companies like software monopolies, while their spending profiles are starting to look more like utilities, telecoms, railroads, or energy infrastructure operators.

That is not a small change.

It does not mean AI is fake. It means the business model economics are changing.

Railroads were real. The internet was real. Smartphones were real. Cloud computing was real. But even real technological revolutions can become bad investments when too much capital is spent too quickly at too high a valuation.

That is where the debate should be.

Not “is AI real?”

The better question is:

How much capital must be spent before shareholders see the return?

Big tech is becoming big capex

The AI buildout has changed the financial profile of the largest companies in the world.

They are not just competing for users anymore. They are competing for compute. They are competing for engineers, chips, electricity, cooling systems, land, fiber, and time.

Goldman Sachs estimates annual AI capex could reach $765B in 2026 and rise to $1.6T by 2031.

Those are not normal numbers.

Those are nation-state numbers.

For context, that kind of spending begins to look less like a normal corporate investment cycle and more like a full industrial buildout. It is not a software upgrade. It is a power-grid, chip-supply, data-center, and infrastructure race.

Again, that may be justified.

But investors should stop pretending it is free.

Capex hits in several ways.

First, it consumes cash that could otherwise go to buybacks, dividends, acquisitions, or balance sheet flexibility.

Second, it raises depreciation later. A data center does not politely disappear from the income statement after it is built.

Third, it increases the pressure to monetize AI quickly. Spending first and finding the revenue later works in bull markets. It becomes less charming when rates rise, inflation returns, or growth slows.

Fourth, it changes the personality of the business. Investors used to pay premium multiples for big tech because it was high-margin, asset-light, and cash-rich. If the next phase is lower free cash flow, higher capital intensity, and uncertain payback periods, the multiple deserves a serious debate.

This is the heart of the issue.

The market is treating AI capex as if every dollar is automatically productive.

History says that is dangerous.

The first wave of infrastructure in every major technology cycle usually overbuilds. Fiber in the late 1990s. Telecom networks. Data centers. Railroads before that. The infrastructure often survives. The early investors do not always get paid.

That is the difference between a real technology and a good stock.

IPO waves are not charity events

A hot IPO market is often described as a sign of confidence.

And yes, it can be.

Companies do not go public when investors are hiding under the bed. Bankers do not ring bells when the market is closed. Founders do not sell dreams into a vacuum.

But IPO waves reveal something else.

They reveal when private owners think public markets are willing to pay up.

That is not evil. That is capitalism.

But investors should understand which side of the table they are sitting on.

Jay Ritter’s long-run IPO data shows why investors should be careful. IPOs can deliver exciting first-day gains, but from the first-day closing price, the average three-year return has historically underperformed the market by roughly 19% to 21%, depending on the dataset and measurement window.

That is the uncomfortable IPO math.

The party is often great on day one.

The hangover tends to arrive later.

This matters because IPO supply is not just a sign of confidence. It is also liquidity extraction. When a mega IPO comes to market, capital has to come from somewhere. Portfolio managers sell or trim other names to make room. Retail investors chase the new shiny object. Institutions rotate. Indexes eventually rebalance. Money that was supporting existing public equities gets redirected toward new supply.

Sometimes the market can absorb it.

Sometimes it cannot.

The difference is liquidity.

In 1999 and 2000, investors believed the internet changed everything. They were right about the technology and wrong about the price. The Nasdaq rose 86% in 1999 alone, peaked in March 2000, then fell 77% by October 2002.

In 2021, investors believed innovation changed everything. Again, not entirely wrong. Software, digital finance, electric vehicles, crypto infrastructure, biotech, and AI-adjacent platforms were real themes. But the IPO and SPAC wave pulled too much optimism into present prices. When inflation rose and rates repriced, many of those stocks collapsed.

That is the lesson.

A great theme does not protect you from a bad entry.

Good company.

Bad price.

Painful outcome.

The next IPO wave could be different, but not harmless

The current IPO setup is not identical to 2021.

That matters.

In 2021, the market was full of smaller speculative listings, SPACs, early-stage growth stories, and companies with thin public-market discipline. A lot of those businesses were sold on dreams, not numbers.

This next wave may be more concentrated and more serious.

We are talking about potential mega-listings tied to companies like SpaceX, OpenAI, and Anthropic. These are not random concept stocks. They are central to the most important themes in the market: AI, space infrastructure, defense technology, compute, and frontier innovation.

That makes them more credible.

It also makes them more dangerous from a liquidity perspective.

Reuters recently estimated that mega-listings from companies like SpaceX, OpenAI, and Anthropic could push 2026 U.S. IPO proceeds to roughly $285B, close to the 2021 peak of $318B.

That is a huge amount of supply.

And because the names are so large and so important, investors may feel forced to participate. That is where the crowding risk comes in. If portfolio managers need to fund new mega-IPOs, they may trim existing mega-cap winners. If retail investors chase the new public AI names, money may rotate out of the old AI winners. If the IPOs trade well, they could fuel another leg of speculation. If they trade poorly, they could damage the entire growth narrative.

That is why IPO supply matters.

It is not just about whether a company is good.

It is about whether the market has enough fresh capital to absorb the supply without weakening the stocks that got us here.

Oil is not just an energy story

Oil is the most underestimated tax in the economy.

It hits consumers at the gas pump. It hits airlines through jet fuel. It hits trucking, shipping, chemicals, plastics, agriculture, packaging, and food distribution. It hits small businesses that cannot hedge. It hits lower-income households hardest because fuel and food take a bigger share of monthly spending.

When oil spikes for a week, markets can ignore it.

When oil stays high for more than three months, it starts moving through the economy like water through a cracked ceiling. First you see the stain. Then you realize the whole structure is wet.

That is where the current setup matters.

The EIA’s June 2026 outlook has warned that under its Strait of Hormuz disruption assumption, Brent crude could average around $105 per barrel in June and July, with inventories heading toward very low levels.

That is not a harmless oil headline.

That is a real macro input.

The 2007 to 2008 oil shock is a useful reminder. Crude prices climbed to around $145 per barrel in July 2008. Oil did not cause the financial crisis by itself. That would be too simplistic. But it arrived at exactly the wrong time. It squeezed consumers, lifted headline inflation, pressured margins, and reduced policy flexibility.

That is what oil shocks do.

They slow growth and lift inflation at the same time.

That is the worst kind of problem for policymakers.

If growth slows, the Fed wants to ease.

If inflation rises, the Fed wants to stay tight.

When both happen together, the Fed loses flexibility.

Markets love the idea of the Fed put.

Persistent oil inflation can take that put out of the money.

Inflation is no longer yesterday’s problem

The market spent a lot of time celebrating disinflation.

That made sense. Inflation came down from the panic levels of 2022. Supply chains normalized. Goods inflation cooled. Shelter inflation slowed. The Fed got closer to the point where rate cuts could be discussed without sounding irresponsible.

But inflation is not dead.

It was resting.

The latest CPI data is a warning shot. Headline CPI rose 4.2% year over year in May. Energy rose 23.5% year over year. Gasoline rose 40.5%. Energy accounted for more than 60% of the monthly increase.

That matters because households live in the headline economy.

Investors love to say “core is what matters.” Consumers do not buy core gasoline, core electricity, or core groceries.

When energy rises, people feel poorer.

When people feel poorer, they either spend less or demand higher wages. One hurts revenue. The other hurts margins. Sometimes both happen.

For companies, inflation is not just an economic statistic. It is a profit test.

• Can they pass through higher costs?

• Can demand hold?

• Can margins survive?

• Can valuations stay high if rates do not fall?

That last question is the big one for growth stocks.

High-multiple technology shares do best when inflation is calm, rates are stable or falling, and long-term earnings are discounted at friendly rates. If inflation rises again and the market has to reconsider the path of rates, long-duration growth becomes more vulnerable.

That does not mean a 2022-style collapse is guaranteed.

It means the cushion is thinner than investors think.

Midterm years are built for anxiety

Now bring in politics.

Midterm election years are rarely calm. They are designed to be loud. Every problem becomes a campaign issue. Every price increase becomes a talking point. Every geopolitical event becomes a loyalty test. Every economic weakness becomes someone’s fault.

Markets do not care about politics in the way cable news wants them to.

Markets care about uncertainty.

They care about fiscal policy, regulation, taxation, trade, energy policy, deficits, tariffs, subsidies, and the probability that businesses delay decisions because they do not know what rules they will be operating under.

Historically, midterm years have been more difficult for equities than other years in the presidential cycle. They have often brought higher volatility in the months leading into the election, even though the period after midterms has frequently been better once uncertainty clears.

That is not a crash forecast.

It is a volatility warning.

The irony is that midterm weakness has often created opportunity. Markets have frequently done better after the uncertainty clears. But that does not remove the risk before the vote.

Before midterms, markets worry. After midterms, markets move on.

The question is whether investors have to endure a repricing first.

This year, the political backdrop is not happening in isolation. It is happening alongside oil pressure, inflation pressure, AI capex pressure, and possible mega-cap equity supply.

That is what makes it different.

Midterm noise is manageable when the economy is calm.

It becomes more dangerous when households are angry about prices, companies are defending margins, and the market is priced for perfection.

This is really a liquidity story

The common thread across all these risks is liquidity.

That sounds technical, but it is actually simple. Liquidity is the oxygen of a bull market. When there is plenty of it, investors can fund new IPOs, tolerate expensive valuations, absorb higher costs, and keep paying up for future growth. When liquidity tightens, the same stories become harder to support.

That is why this setup deserves attention.

IPO waves and secondary offerings do not just create headlines. They create new supply that the market has to absorb. AI capex does not just show ambition. It consumes corporate cash that could otherwise go toward buybacks, dividends, acquisitions, or balance sheet flexibility. High oil does not just hurt energy consumers. It drains household spending power. Inflation does not just bother economists. It reduces the Fed’s room to cut and raises the hurdle for valuation multiples.

One of these forces alone can be manageable.

Together, they can change the character of a market.

A bull market needs oxygen from earnings growth, falling rates, expanding liquidity, buybacks, risk appetite, or multiple expansion. Ideally, it gets several at once. This setup threatens several at once.

If big tech spends more, buyback growth may slow. If IPO supply rises, capital has more places to go. If oil stays high, consumers have less discretionary income. If inflation stays firm, the Fed has less room to help. If midterm uncertainty rises, investors demand a higher risk premium.

That is the thesis.

Not that every risk guarantees a bear market.

The danger is that each risk pushes in the same direction: less excess liquidity, lower policy flexibility, tighter margins, and less room for valuation mistakes.

That is how markets usually get into trouble.

Slowly at first. Then all at once.

The mistake investors make at all-time highs

All-time highs are not automatically bearish.

This is important.

Strong markets make new highs. Bull markets live at new highs. Selling simply because the market is at a record is not a strategy. It is usually just fear dressed up as discipline.

But all-time highs do change the standard of proof.

When the market is at a high, investors should ask harder questions.

• Are earnings accelerating fast enough to justify the move?

• Is the rally broadening or narrowing?

• Are valuations supported by cash flow or just narrative?

• Are companies returning capital or consuming it?

• Is inflation falling or returning?

• Is the Fed gaining flexibility or losing it?

• Is new equity supply being absorbed easily or starting to crowd out existing names?

The market does not become dangerous because it reaches a high.

It becomes dangerous when it reaches a high while the foundation underneath starts getting more expensive, more political, more capital-intensive, and more inflation-sensitive.

That is the current concern.

What history actually teaches

The lazy bearish comparison is to say, “This is 2000.”

It is not.

The companies leading today’s market are much stronger than the average dot-com darling. They have real earnings, real cash flows, real customers, real balance sheets, and real strategic advantages.

But the lazy bullish response is just as dangerous: “Because this is not 2000, there is nothing to worry about.”

Markets do not need to repeat history to rhyme with it.

The useful lesson from 2000 is not that technology was fake. The useful lesson is that even real technological revolutions can be overcapitalized and overpriced.

The useful lesson from 2008 is not that oil alone causes bear markets. It does not. The lesson is that a major oil shock can arrive at exactly the wrong time and squeeze an already vulnerable economy.

The useful lesson from 2021 is not that innovation was worthless. The lesson is that when too much capital chases the same growth story at the same time, future returns get pulled into the present. After that, the business can keep growing while the stock goes nowhere or worse.

That is the uncomfortable part investors need to accept.

AI may transform the economy. Big tech may remain dominant. Some IPOs may become massive long-term winners. Oil may cool later this year. Inflation may settle. The market may survive midterms.

All of that can be true.

But at all-time highs, investors are not paid for “maybe everything works out.” They are paid when expectations are too low.

Right now, expectations do not look low.

What would make me more concerned

The first warning sign would be oil staying elevated for longer than the market expects.

Not one spike. Not one headline. Persistence.

If oil remains high for several more months, the inflation debate changes. Companies will have to discuss energy costs more directly. Consumers will feel it. The Fed will have a harder time sounding relaxed. Bond yields could become more volatile.

The second warning sign would be big tech capex continuing to rise without clear evidence of near-term returns.

Investors can tolerate spending when revenue acceleration follows. They become less patient when the spending becomes defensive. There is a big difference between “we are investing because demand is exploding” and “we are investing because if we do not, a competitor will.”

The third warning sign would be IPOs being priced aggressively and trading poorly after the first-day excitement fades.

That would tell us supply is starting to overwhelm demand. The first day of an IPO is theater. The next few months are truth.

The fourth warning sign would be market breadth weakening while indexes stay near highs.

That is when the headline index lies. A market can look healthy because a handful of giants are holding it up, while the average stock is already correcting underneath.

The fifth warning sign would be a shift in Fed language.

If inflation pressure forces the Fed to sound less friendly, the equity market has to reprice the discount-rate fantasy. That is especially relevant for the most expensive parts of the market.

What would make me less concerned

Oil cooling quickly would help.

A clear decline in energy inflation would give the Fed breathing room and support the consumer.

Big tech showing that AI capex is translating into real revenue, not just bigger data centers, would help.

IPO discipline would help. Reasonable valuations, strong balance sheets, and selective issuance would be much healthier than a flood of “story stocks” trying to squeeze through the window before it closes.

Broader market participation would help. If industrials, financials, healthcare, small caps, and equal-weight indexes begin confirming the rally, the market becomes less dependent on the same narrow leadership group.

And finally, valuations coming down without earnings breaking would help. A controlled correction can be healthy. It resets expectations. It removes excess. It reminds investors that risk still exists.

Bull markets do not die because stocks fall 5% or 10%.

Sometimes that is how they stay alive.

How I would think about positioning

This is not a market where investors need to panic. It is a market where investors should stop being sloppy.

The right response is not “sell everything.” The right response is higher standards.

I would be more selective with entries. When markets are stretched and risks are stacking, price matters more. Chasing vertical moves in crowded AI names may feel safe because everyone else is doing it. That is exactly why it becomes dangerous.

I would focus more on free cash flow than revenue growth. In a cheap-money environment, revenue stories can dominate. In a higher-inflation, higher-capex environment, cash generation matters more. The market may eventually reward companies that can fund growth internally and punish companies that constantly need external capital.

I would pay closer attention to balance sheets. Companies with low refinancing needs, strong cash positions, and durable margins have more room to make mistakes. Companies that need capital markets to stay friendly are more fragile.

I would watch oil persistence, not oil headlines. One-day moves are noise. Three-month pressure is signal.

I would be careful with IPO enthusiasm. A great company can still be a poor investment if the public market entry price already assumes perfection. The question is not “do I like the company?” The question is “what return am I being offered from this valuation?”

I would keep some liquidity available. Cash is not exciting, but optionality rarely looks exciting before it matters. In markets priced for perfection, cash gives investors the ability to buy from forced sellers instead of becoming one.

And I would avoid confusing index strength with market health. If the market is rising because five names are carrying everything, that is not the same as broad risk appetite. Breadth matters.

This is a market for discipline, not drama.

The bottom line

This is a market that deserves respect, not blind trust.

The bull case is still visible. AI investment is real. Corporate America is not collapsing. The largest companies in the index are not profitless dreams. There is still liquidity in the system. There is still long-term innovation.

But the risk stack has changed.

• Big tech IPOs and possible equity issuance create supply.

• Big tech capex creates free cash flow questions.

• High oil creates inflation pressure.

• Inflation limits the Fed.

• Midterms increase uncertainty.

• All-time highs reduce the margin of safety.

That is the perfect storm.

Not because every piece guarantees a crash.

Because every piece points in the same direction: less liquidity, less policy flexibility, more uncertainty, and higher expectations at exactly the wrong time.

The market may keep climbing. Momentum can last longer than skeptics expect. Expensive markets can become more expensive. Investors who sell every warning sign usually spend a lot of time watching from the sidelines.

But this is not the moment to confuse confidence with invincibility.

When everything is priced for sunshine, you do not need a hurricane to cause damage.

Sometimes a few dark clouds are enough.

This article is for informational and educational purposes only and is not financial advice or a recommendation to buy or sell any security. Markets involve risk, and past performance does not guarantee future results. Please do your own research and consult a qualified financial advisor before making investment decisions.

The jobs-report scare that broke the tape a week ago was largely unwound this week, and the broad indexes climbed back above their trend.

Yields eased as the rate panic faded, with the 2-year slipping to 4.09% from 4.17% and the 10-year easing to 4.48% from 4.55%, and volatility cooled, the VIX falling from its spike near 21 back toward 17 by Friday after a brief midweek pop.

SPY gained 0.6% on the week to 741.75 and QQQ rose 2.3% to 721.32, both reclaiming their Trend-Hold and both closing Friday green. Credit never flinched, with high-yield spreads steady all week, confirming this was a rate scare rather than a stress event.

The standout was the rotation beneath the surface. The semiconductors that were crushed in the Friday selloff staged a violent V-shaped recovery off the washout low: Intel rallied 26%, Applied Materials 25%, Lam Research 21%, ASML 14%, and AMD 10%, dragging the chip complex and the Nasdaq back into Trend-Hold alongside Taiwan Semi.

Money also rotated into cyclicals and defensive value, with copper miners reclaiming Trend-Hold, Target up 10% and Dollar General up 11% leading retail, Oscar Health up 15%, and Costco, Lockheed, Nike, and Walmart all repairing off their lows.

The clear loser was mega-cap software: Oracle fell 14% and Adobe 19% on disappointing earnings, Microsoft bled steadily into a Breakdown, Apple lost its Trend-Hold, and Intuit stayed broken. The week ahead is dominated by the Federal Reserve, whose rate decision and updated projections land Wednesday, June 17, the single event most likely to set direction for the rate-sensitive groups that just recovered.

What Changed From Last Week

• Reclaimed Trend-Hold: AMD, COPX, FTI, INTC, LRCX, QQQ, SPY, TGT, TSM, XOVR. The strongest signal of the week, structure fully repaired.

• Lifted out of Breakdown into Transitional: DG, NVO, RTX. Early bounces that still need to prove themselves.

• First repair off the lows: COST, LMT, NKE, WMT. Damaged names showing the first sign of basing.

• Cooled out of Trend-Hold into Transitional: AAPL, ORCL, RBRK, RDW. Leaders that lost their trend and now need to re-prove it.

• Lost the trend, into Repair: AMZN, ASTS. Downgraded a full step, treat as damaged until reclaimed.

• Broke down: ADBE, MSFT, PINS, SLV. Fresh damage, the framework moves these to the avoid list.

• Biggest movers: INTC +26%, AMAT +25%, LRCX +21%, OSCR +15% to the upside; ADBE -19%, RDW -18%, ORCL -14%, ASTS -12% to the downside.

How Our Trade Plans Work

Our framework is rules-based and level-driven. We classify each name into a regime (Trend-Hold, Transitional, Repair, or Breakdown) using the 1D EMA stack, cross-checked against the 1W chart. Every entry, target, and invalidation traces back to a specific indicator level. T1 is the first profit-take layer, T2 is the structural objective, T3 is the stretch target on full continuation. Sizing follows the regime: Trend-Hold names take normal size but only on a pullback to support or a confirmed breakout; Transitional names take half size or wait; Repair names take a starter only after a reclaim; Breakdown names are avoided until a reclaim confirms.

Two stops, two jobs. The trade stop protects the position; the regime invalidation changes the thesis. The trade stop is the tactical level where a single trade is wrong and you cut it. The regime invalidation is the deeper level where the entire classification flips to a lower regime and the reason to own the name is gone. They differ on purpose: one manages risk, the other manages conviction.

Cash is a position, and waiting is part of the plan. This update ranks 60 stocks and ETFs: the highest-conviction, near-entry names get a full setup, and the rest are tracked in the watchlist table so nothing in the universe goes uncovered.

This Week’s Playbook

Start here. The detailed setups follow for the top names, and the full watchlist table covers the rest.

• Best risk/reward this week: SPY, QQQ, XOVR, FTI, TSM, COPX (+2 more in the table). Price is already at a defined entry on the 1D EMA20, so the trigger is near and the risk is tight; these are the names that reclaimed or held their trend, the cleanest longs to engage as leadership rotates.

• Best leaders to buy only on weakness: OSCR, UNH, LLY, ASML, LRCX. Clean trends with room to run, but buy the pullback, do not pay up here.

• Most dangerous chase setups: AMAT. Overbought leaders; the trend is real but the entry is not, wait for a reset.

• Avoid until a reclaim confirms: ADBE, BABA, BIDU, ETHA, GLD, INTU, LULU, META, MSFT, NFLX, NOC, PALL, PINS, PLTR, SHOP, SLV, SOFI, XRH0.L, XRPI. No long exposure; not every dip is a setup, and cash is the position.

This update covers the following 60 stocks and ETFs across consumer, technology, healthcare, industrials, and commodities.

Top 5 Actionable Setups

The highest-conviction names sitting closest to a defined entry, with full detail, levels, and both stops for each. The next tier follows in the Also Actionable table, and the rest of the universe in the full watchlist below it.

SPDR S&P 500 ETF Trust (SPY), Last close: 741.75

Setup: The least flashy setup in the book and the cleanest read on broad-market repair, the S&P 500 reclaimed its Trend-Hold as the jobs-report selloff unwound. 1D and 1W both Trend-Hold; price above all four 1D EMAs with the 1D EMA20 at 740.81 as first support. Daily RSI 53.0 (neutral-positive), MACD bearish stabilizing; the tape is digesting, act only at defined levels. Thesis breaks on a daily close below 694.65 (6.3% below current), shifting regime to Transitional.

• Entries: Pullback: 722.48 to 741.01 (1D EMA20 support band, price sitting on it) · Breakout: above 760.40 (20-day high)

• Targets: T1: 760.40 (1D 20-bar high) · T2: 796.06 (1D Fib ext 127.2) · T3: 828.93 (1W Fib ext 127.2)

• Trade risk: Tactical stop on a daily close below 722.59 (1D 20-bar swing low), about 2.6% from current, tighter than the regime invalidation below.

• Stop: Regime invalidation is a daily close below 694.65 (1D EMA200); break shifts to Transitional.

• Holding: Trail below 1D EMA20 (740.81); take partials at T1 (760.40).

• Not holding: Wait for pullback to 1D EMA20 (740.81) or above 760.40.

Invesco QQQ Trust (QQQ), Last close: 721.32

Read more

That is the real thesis going into this meeting. The market wants to know when rate cuts are coming. Investors want confirmation that the inflation fight is almost over. But the Fed is dealing with a much harder question.

Has inflation cooled enough to justify easing, or is the next inflation risk already building through oil?

That is why this meeting matters.

The Fed is fighting two clocks at the same time. One clock is monetary policy. It moves slowly. Higher rates take time to work through the economy. They hit housing first, then credit, then consumer behavior, then corporate spending, hiring, and investment. Only after that does the full pressure usually show up in inflation.

That process can take many months. In some parts of the economy, it can take more than a year.

This is what makes the Fed’s job difficult. It may already have done enough, but it may not know that yet. Current interest rates may still be slowing the economy beneath the surface, even if the headline data still looks stable.

The second clock is oil. Oil moves much faster.

When oil rises, consumers feel it almost immediately at the pump. Businesses feel it through transport, shipping, airline costs, food distribution, and input prices. Oil is not just another line in the inflation report. It touches margins, budgets, pricing decisions, and psychology.

The risk is not only that energy prices rise. The bigger risk is what happens after.

If companies absorb higher energy costs, margins come under pressure. If they pass those costs to customers, inflation becomes harder to bring down. If consumers start expecting prices to keep rising, the inflation problem becomes more emotional and more difficult to control.

That is the second-round effect. And that is what the Fed cannot ignore.

A short oil spike does not automatically change policy. The Fed can look through temporary moves in energy. But if oil stays elevated long enough to affect prices, wages, and expectations, it becomes a problem for the inflation outlook.

This is why a rate cut now would be difficult to justify.

The economy is cooling, but not breaking. The labor market is softer, but not weak enough to force immediate action. Inflation has improved, but it is still not fully back to target. Add oil pressure to that mix, and the Fed has very little reason to rush.

The most likely outcome is a hold. But the decision itself is not the story. The message is.

A softer tone would tell markets that cuts are still possible later this year. That would likely support stocks, ease financial conditions, and bring the market back to the idea that the Fed is close to helping again.

A firmer tone would do the opposite. It would remind investors that the Fed still needs proof. Not one better inflation print. Not one slower growth number. Proof that inflation is moving lower in a sustainable way.

That is the key word. Sustainable.

The Fed does not need inflation to be perfect before it cuts, but it needs confidence that inflation will not reaccelerate once policy becomes easier. Cutting too early could give demand a second life before inflation has fully cooled. Stocks could rally. Credit could loosen. Consumers and companies could feel relief.

That may sound positive in the short term, but it could make the Fed’s job harder later. This is the danger.

If the Fed cuts while oil is pushing inflation pressure back into the system, it risks easing into the wrong environment. That would not be a victory lap. It would be a gamble.

The market is focused on the first cut. The Fed is focused on what happens after the first cut. That difference matters.

Investors want to know when policy becomes easier. The Fed wants to know whether easier policy would restart the very problem it has spent the last two years trying to control. Those are not the same questions.

This is why patience remains the most likely message.

The Fed can stay on hold and let time do more work. It can wait for the lagged impact of higher rates to show up more clearly. It can watch whether inflation continues to cool, whether oil pressure fades, and whether the labor market slows without breaking.

That may frustrate markets, but it is the more responsible path.

The Fed is not in a position to celebrate yet. Inflation has improved, but it has not disappeared. Oil has re-entered the equation at the wrong time. And monetary policy still works with a delay, not a stopwatch.

That leaves the Fed with a narrow path: Cut too early, and inflation could return. Wait too long, and growth could weaken more than expected.

For investors, the conclusion is clear. This is not a meeting about relief. It is a meeting about patience. The market may still be right that the next move in rates is lower. But timing is everything.

Until oil calms down, inflation cools further, and the lagged impact of current rates becomes clearer, rate cuts remain more of a hope than a base case.

This article is for educational and informational purposes only. It does not constitute financial advice, investment advice, or a recommendation to buy or sell any security. Always do your own research and consider your personal risk tolerance before making investment decisions.

Oracle and Adobe both reported this week, both beat, and both fell hard. Oracle is winning the AI buildout, and the market just realized how much that victory costs, sending it down about 10% to near $184 even after record results. Adobe put up a beat-and-raise and fell about 7% to near $204, on doubts it can win in AI at all, plus a leadership transition at the worst possible moment. The reactions look identical. The reasons are mirror opposites: one is a growth darling the market is questioning on cost, the other a former champion it has nearly given up on.

The valuations capture the whole debate. The market pays more than 30 times earnings for Oracle while tolerating negative free cash flow. It pays about 12 times earnings for Adobe despite a double-digit free-cash-flow yield. That spread is the entire story.

Key Takeaways

• Oracle (ORCL) reported record results, revenue up 21% and a signed-contract backlog of $638B, but fell because the capital spending behind that growth is surging and margins are compressing.

• Adobe (ADBE) beat and raised guidance, with AI revenue tripling past $500M, but fell on a departing CFO, a decision to hold prices and chase users, and beats too modest for a doubtful market.

• The valuations are night and day: ORCL near 31 times trailing earnings with free cash flow negative; ADBE near 12 times trailing, around 8 times forward, with a free-cash-flow yield above 12%.

• The Street agrees with the split. Oracle is still rated a buy, down only about 13% over the past year; Adobe is rated a hold, down roughly 49%.

• Oracle is a great business at a rich price absorbing a cost shock. Adobe is a cheap, profitable business the market believes is in decline. Neither is an easy call.

Start with the more expensive problem.

Oracle (ORCL): The Cost of Winning

Oracle’s quarter was, by the numbers, a triumph. Revenue rose 21% to a record $19.2B, cloud revenue jumped 47% to $9.9B, and adjusted earnings of $2.11 a share beat the $1.96 expected. The figure that stunned everyone was the backlog: remaining performance obligations, the value of signed contracts not yet delivered, hit a record $638B, stuffed with long-term deals to supply AI computing power. Full-year operating cash flow surged 54% to a record $32B. Demand is clearly not the problem.

So why did the stock fall about 10%? Because winning is turning out to be brutally expensive. To deliver that $638B backlog, Oracle has to build data centers at staggering scale, and its capital intensity is stepping up well beyond what the market had penciled in. The cost of running the cloud is now growing faster than cloud revenue, expenses up 56% against 47% revenue growth, so margins are set to shrink near term. And the cash tells the story: even with operating cash flow at a record $32B, the spending behind the buildout has swung free cash flow negative, with debt climbing to nearly 4 times equity to fund it.

That’s the tension in one frame: elite margins and a fortress of demand, paid for with negative free cash flow and rising debt. At 31 times trailing earnings, Oracle was priced for a flawless buildout. The results were great. The bill for them was the surprise.

Net read: A genuine AI winner whose cost just came into focus. The demand isn’t in question; the capital intensity and cash burn are. At $184, down about 26% from its high, it’s cheaper than it was, but still has to prove the spending pays off.

Now the cheaper, scarier problem.

Adobe (ADBE): Priced for Decline

Adobe’s quarter was quietly strong. Revenue rose 13% to a record $6.62B, beating estimates, and adjusted earnings of $5.96 a share topped the $5.81 expected. The company raised its full-year outlook, its AI-first products more than tripled their recurring revenue to over $500M, and total recurring revenue reached $27.1B. On the scorecard, a beat-and-raise.

The stock fell about 7% anyway, for reasons that have little to do with the quarter. First, leadership: the chief financial officer is leaving within days, a second C-suite opening alongside an ongoing search for a new chief executive, a rare transition at exactly the wrong moment. Second, strategy: Adobe will hold off on price increases and lean into free, “freemium” versions of its AI products to grow users, which pressures near-term revenue and reads, to a nervous market, like defense against AI rivals rather than confidence. Third, expectations: the beats were modest, and modest doesn’t cut it for a stock the market already fears is being disrupted.

Here’s what makes Adobe fascinating: the fear is extreme, and the business is still excellent. It runs a 34% operating margin and a 63% return on equity, throws off more than $10B of free cash flow for a yield above 12%, and carries little debt. Yet it trades near 12 times trailing earnings and around 8 times forward, a fraction of its historical multiple and a quarter of Oracle’s. The market isn’t pricing a slowdown; it’s pricing decline, a bet that generative AI commoditizes the software Adobe has owned for decades.

Net read: A cash machine the market has left for dead. That doesn’t make it automatically cheap enough. Down roughly 49% on the year and rated only a hold, it’s priced as if its best days are gone. Whether that’s a gift or a trap rests on a question this quarter didn’t answer: can Adobe turn AI into a moat instead of a threat?

The Technical Picture

The tape makes the difference plain: Oracle and Adobe are not broken in the same way. Oracle is unwinding from euphoria, a stock falling back to earth after a vertical run. Near $184, it’s just snapped below its 20-day, 50-day, and 200-day averages, the last near $190, with momentum weak but not yet washed out. That’s a high-flyer cooling off, not a collapse.

Adobe is the opposite: trying to form a bottom after a long, grinding de-rating. Near $204, it sits far below its 200-day average around $294, just above its prior low near $197, with momentum genuinely oversold. Its relative strength index, a 0-to-100 momentum measure where under 30 signals oversold, is down at 29 on both the daily and weekly. That says a bounce is overdue, but a bounce in a downtrend isn’t a bottom.

How to Position

These are levels to watch, not instructions, and both stories are still developing.

Read more

Copper and palladium sit side by side on the commodities shelf, but they’re headed in opposite directions, and so are the funds built on them. COPX, the Global X Copper Miners ETF, owns the companies that dig up copper, the metal of electrification, and it’s riding one of the clearest structural demand stories in the market.

PALL, the abrdn Physical Palladium Shares ETF, holds bars of palladium, a metal whose biggest customer, the gasoline engine, is being designed out of existence. Copper trades near $6.40 a pound, up about 34% over the past year and close to record highs. Palladium sits near $1,300 an ounce, an 8-month low and roughly 57% below its 2022 peak. Both got swept up in last week’s rate-driven selloff and bounced. That’s where the similarity ends.

Key Takeaways

• COPX, the Global X Copper Miners ETF, is a high-beta proxy for copper, the metal of electrification. It holds copper miners, not physical metal, so it amplifies copper’s moves in both directions.

• PALL, the abrdn Physical Palladium Shares ETF, holds physical palladium, a metal facing structural demand destruction as electric vehicles replace the catalytic converters that consume most of it.

• The prices tell the story. Copper is near $6.40 a pound, up about 34% on the year near record highs; palladium is near $1,300 an ounce, an 8-month low and about 57% below its 2022 peak.

• The setups are mirror opposites. COPX sits above its 200-day average in an uptrend that just pulled back; PALL trades below all its major averages in a clear downtrend.

• Copper is the easier long. Palladium only works for contrarians betting on a supply shock, because the demand trend is against it.

Start with what each fund actually holds.

What COPX and PALL Actually Own

COPX, the Global X Copper Miners ETF, does not hold copper. It owns the companies that produce it, including Freeport-McMoRan, Southern Copper, and Ivanhoe Mines. That makes it a high-beta copper proxy, not a direct bet on the metal itself.

The distinction matters. Miners carry operating leverage. When copper rises, their profits can rise faster because much of the cost base is fixed. That also cuts the other way, which is why COPX can move harder than copper in both directions. It is not a leveraged ETF, but in a strong copper cycle, it can behave like one.

PALL is the opposite. The abrdn Physical Palladium Shares ETF holds physical palladium bullion in vaults and tracks the metal’s spot price, minus fees. No miners. No earnings leverage. No operating upside. Just direct exposure to what the market will pay for palladium.

That is the first big split: COPX owns businesses tied to a metal with rising strategic demand. PALL owns a metal whose main customer is slowly disappearing.

Copper: The Metal Behind Electrification

Copper has the cleaner long-term story.

It sits at the center of electrification: power grids, electric vehicles, renewables, battery storage, and AI data centers that need more electricity, wiring, and cooling infrastructure. The world cannot electrify without copper.

The supply side is the problem. New mines are slow, expensive, politically difficult, and often take more than a decade to move from discovery to production. So while demand keeps building, supply cannot respond quickly. That is what gives copper its structural deficit story.

But this is not a straight line. Copper is still tied to the real economy. If China weakens, manufacturing slows, or global growth fears rise, copper can sell off fast. COPX usually feels that even more because miners are equities with commodity exposure, not just commodity exposure.

So the trade-off is clear: copper has one of the strongest demand stories in commodities, but COPX will still shake hard when macro fear hits.

Palladium: The Metal Losing Its Main Customer

Palladium has the opposite setup.

Its biggest use is in catalytic converters for gasoline vehicles. That was once the bull case. Now it is the problem. Electric vehicles do not need catalytic converters, and automakers have spent years substituting cheaper platinum where they still can.

So palladium is getting squeezed from both sides: fewer combustion engines over time, and less palladium used in the ones that remain.

That is why palladium rallies feel different from copper pullbacks. Copper dips inside a demand story that is still expanding. Palladium bounces inside a market where demand is being designed away.

That does not mean palladium cannot rip. It can. Supply is concentrated in Russia and South Africa, so sanctions, mine disruptions, power shortages, or labor issues could trigger a sharp squeeze. After a long decline, the metal is vulnerable to violent countertrend rallies.

But that is the point. Palladium needs a catalyst. Copper has the tailwind.

COPX is volatility inside a structural bull case. PALL is a contrarian trade waiting for something to break.

The Technical Picture

The tape mirrors the fundamentals. COPX, near $83 with copper around $6.40 a pound, hovers at its 50-day average near $84 and sits well above its 200-day near $74, having bounced off about $77. Its daily relative strength index, a 0-to-100 momentum gauge where under 30 is oversold and over 70 overbought, is a neutral 48. This is a healthy uptrend taking a breather, not a breakdown.

PALL, near $23 with palladium around $1,300 an ounce, tells the opposite story. It trades below its 20-day, 50-day, and 200-day averages, all of which slope down, the textbook look of a downtrend. Its momentum gauge sits at 39, weak but not yet washed out, which means it isn’t even oversold enough to bank on a sharp bounce. Until PALL reclaims its falling averages, the path of least resistance is sideways to lower.

How to Position

These are levels to watch, in fund and metal terms where it helps, not instructions.

Read more

Precious metals just had their roughest stretch of the cycle. Gold fell to about $4,160 an ounce, a 6-month low and 25% below its January peak near $5,589, dragging the big gold fund, GLD, down to roughly $375 a share. Silver fell harder, to about $64 an ounce, taking the silver fund, SLV, to roughly $58. Over the past week alone GLD lost about 8% and SLV about 13%.

The trigger wasn’t a collapse in the case for metals. It was rates: a strong jobs report and rising inflation pushed the Federal Reserve further from cutting and closer to hiking, lifting bond yields and making non-yielding gold and silver less attractive by comparison. Inflation rose and gold fell, which only seems strange until you remember what actually moves the metal.

Key Takeaways

• Gold fell to about $4,160 an ounce, a 6-month low and 25% below its January high near $5,589; GLD, the gold ETF, sits near $375. Silver dropped to about $64; SLV trades near $58.

• It’s a rate story. A strong jobs report and rising inflation lifted yields, the 10-year above 4.5% and the 30-year above 5%, and higher real yields are the main enemy of metals that pay no income.

• Silver fell harder for a reason. It’s half an industrial metal and far more volatile; over the past week SLV lost about 13% to GLD’s 8%.

• The gold/silver ratio jumped to about 65 from 55 in May, meaning it now takes 65 ounces of silver to buy one ounce of gold. A ratio in the 60s has often come before silver catching up in a recovery.

• Both are deeply oversold at multi-month lows, a correction within a longer uptrend, not a confirmed top. But the catalyst is the Fed, and that isn’t resolved, so patience beats heroics.

Start with what these funds actually are.

What GLD and SLV Are

• GLD is the SPDR Gold Shares ETF, the largest and most liquid way to own gold without storing bars yourself. It holds physical gold in a vault, and each share represents a small slice, currently just under a tenth of an ounce, so the share price runs near a tenth of the spot gold price. With gold near $4,160 an ounce, GLD trades near $375. Its expense ratio is 0.40%, fine but not the cheapest; a near-identical fund, IAU, charges 0.25% for the same gold exposure.

• SLV is the iShares Silver Trust, the silver equivalent. It holds physical silver, and each share tracks just under an ounce, so with silver near $64 an ounce, SLV trades near $58. Its fee is 0.50%. Both funds do one job: hold the metal and track its price, minus a small drag from fees over time. Neither pays a dividend, because metal generates no income.

Why Silver Fell Harder

Gold and silver rhyme, but they aren’t the same trade. Gold is mostly a monetary asset, a store of value that central banks and investors hold when they distrust paper money or want a hedge. Silver is a hybrid: part safe haven, part industrial input, with roughly half its demand coming from solar panels, electronics, and manufacturing.

That industrial side makes silver more economically sensitive and far more volatile. It tends to move like gold with the volume turned up, rising more in rallies and falling more in selloffs. This past week was the falling-more kind: SLV dropped about 13% (silver from about $73 to $64 an ounce) while GLD fell about 8% (gold from about $4,530 to $4,160).

The gauge that captures their relationship is the gold/silver ratio, simply the gold price divided by the silver price, or how many ounces of silver it takes to buy one ounce of gold. It just jumped to about 65 from 55 in May, meaning silver got cheaper relative to gold. That doesn’t mean silver has to rebound first. But it does show silver has quickly become cheaper relative to gold, and if the metals complex stabilizes, silver usually has more catch-up torque. For investors who think the selloff is a pause rather than an end, that tilts the higher-risk dollar toward silver, and SLV.

What Just Happened

The metals didn’t break on their own story. They broke on rates. A strong May jobs report landed first, with payrolls up 172,000 and unemployment steady at 4.3%, then inflation data showing prices still climbing: headline May inflation jumped to 4.2%, though core held lower at 2.9%.

Together they pushed the Fed away from cuts and toward the possibility of a hike, and the bond market repriced fast: the 10-year Treasury yield climbed above 4.5% and the 30-year above 5%. Here’s the key idea in plain terms. Gold and silver pay no interest, so when real yields (what bonds pay after inflation) rise, the opportunity cost of holding a lump of metal goes up, and money rotates out.

A flare-up in the Iran conflict, which would normally send gold higher as a haven, wasn’t enough to offset it. The result was gold’s deepest pullback of the cycle, 25% off its January high.

The Technical Picture

Both metals are stretched to the downside. GLD trades near $375 (gold about $4,160 an ounce), pinned to a fresh 6-month low, with its daily relative strength index, a 0-to-100 momentum gauge where under 30 signals oversold, down at 24. It sits below its 20-day, 50-day, and 200-day averages, the last of which is near $401 (gold about $4,455) and now the first overhead hurdle to win back.

SLV near $58 (silver about $64) tells the same story, its momentum gauge down at 30 and price below its 200-day near $61 (silver about $68). Readings this washed out often precede a bounce, but a bounce inside a downtrend is not the same as a bottom. The bigger picture still favors the bulls only if the longer uptrend holds. These are deep corrections, not yet reversals.

How to Position

These are levels to watch, in both share and spot terms, not instructions. Be clear about what this is: not a breakout setup, but an oversold-reversal watchlist, with both funds still below their major moving averages. Rates are the swing factor, and if yields keep climbing, oversold can get more oversold.

Read more

The access was the whole point. With the IPO here, the easy part of that trade is nearly over.

SpaceX is about to go public. It has set its IPO at $135 a share, raising roughly $75 billion at about a $1.75 trillion valuation, the largest offering on record, with trading expected to begin around June 12 on Nasdaq under the ticker SPCX. For years, regular investors had no way to own a piece. XOVR, the ERShares Private-Public Crossover ETF, was the workaround: a normal-looking $20 fund that holds a real, if indirect, stake in SpaceX. That access is why people bought it.

But here’s the blunt truth most headlines skip: XOVR is not a SpaceX ETF. It’s a growth-stock ETF with a SpaceX allocation. SpaceX is the largest single holding, but it’s a minority of the fund, and the rest is a concentrated basket of public tech names. That gap matters more than ever right now, because the IPO that finally validates the SpaceX position is also the event that strips XOVR of the one thing that made it special.

Key Takeaways

• XOVR is not a pure SpaceX play. SpaceX is the biggest holding, but it’s a minority of the fund; the other roughly 85% is an active, concentrated portfolio of public growth and AI stocks.

• The access was the draw. XOVR let ordinary investors own SpaceX before the IPO, through a special-purpose vehicle, at a $20 share price. That edge disappears the day SPCX starts trading.

• The IPO is priced, and it’s steep. At $135 a share, SpaceX is valued near $1.75 trillion, roughly 94 times its 2025 revenue, despite posting a net loss of about $4.9 billion last year.

• Wall Street is skeptical of the price. Morningstar pegs SpaceX’s fair value near $780 billion, less than half the IPO valuation, and warns the deal demands flawless execution.

• It isn’t cheap, and it hasn’t delivered. ERShares lists a 0.75% management fee, well above a basic index fund, and XOVR is down about 2% in 2026 while the S&P 500 is up around 9%.

Start with what you’re actually holding.

XOVR Is Not a SpaceX ETF

The fund’s full name, the ERShares Private-Public Crossover ETF, captures the pitch: it crosses public stocks with private, pre-IPO companies, the latter being how SpaceX got in. In practice, though, the public side dominates. SpaceX gets the headlines, but it’s a minority of the fund. ERShares pegged the position near 23% of assets in late May, about $292 million of exposure; since then the fund’s assets have grown quickly, and on the current, larger base that same stake works out closer to the low teens.

Either way, the other roughly 85% is what drives XOVR day to day, and that sleeve is an active, concentrated bet on public growth and AI names: NVIDIA at 11%, Alphabet at 7%, the AI-connectivity chipmaker Astera Labs at 6%, and Meta at 5%, followed by a tail of momentum favorites like AppLovin, Robinhood, Reddit, Rocket Lab, MongoDB, and Affirm. The top 10 positions are about 60% of the fund across just 33 holdings.

That mix explains a lot. These are exactly the rate-sensitive, richly valued growth stocks that fell hardest when yields jumped on June 5, which is why XOVR dropped with the rest of tech that day. It also explains the performance: despite owning the most hyped pre-IPO asset on earth, XOVR is down about 2% in 2026 while the S&P 500 is up around 9%. With the SpaceX mark mostly sitting still, the public basket has set the returns, and it hasn’t kept pace.

And you pay for the privilege. ERShares lists a 0.75% management fee, modest for an active fund but many times the cost of a plain S&P 500 ETF, and you pay it on the whole portfolio, not just the SpaceX slice.

The Access Trade, and the SpaceX Behind It

So why did billions still flow in? Access. Until now, owning SpaceX meant being an insider or an accredited investor buying secondary shares. XOVR cracked that door open for a $20 share price, holding its stake indirectly through a special-purpose vehicle, a separate legal entity that owns SpaceX interests and that the fund invests in. XOVR doesn’t own SpaceX shares directly; it owns a piece of the vehicle that does. Because there’s no live market price, that position is a Level 3 asset, valued by the manager’s estimate of fair value rather than a quote, and XOVR currently carries it near a $1.55 trillion valuation.

The company behind it is no longer just rockets. There’s the launch arm that puts more payload into orbit than the rest of the world combined; Starlink, the satellite-internet network that booked $11.4 billion of revenue in 2025 with more than 10 million customers; and a growing AI arm after SpaceX absorbed xAI earlier this year. ERShares’ investment chief has called it potentially one of the most consequential IPOs the public market has ever seen. That may be true from an access and demand standpoint. But consequence and price are different things, and a historic company can still be a poor investment if the entry valuation already banks too much of the future.

There’s a small, real upside for XOVR in the event itself. The IPO priced about 13% above the fund’s $1.55 trillion mark, so when XOVR remarks the position to the public price, its net asset value should tick up. But at a low-teens weight that’s a low-single-digit lift, not a windfall, and it’s a one-time step, not a thesis.

The Price Problem

This is where the excitement needs a cold shower. SpaceX may be one of the most important companies in the world, but importance and valuation are not the same thing. The company generated $18.67 billion of revenue in 2025 and posted a net loss of about $4.9 billion. At $135 a share, the IPO values it near $1.75 trillion, roughly 94 times trailing revenue, more than 4 times the revenue multiple the market pays for NVIDIA. At that price, investors aren’t paying for rockets and Starlink as they exist today. They’re paying for years of flawless execution across launch, broadband, AI, defense, and orbital infrastructure that doesn’t exist yet. That may prove right. It also leaves almost no room for disappointment.

And it’s not just an opinion. Morningstar’s analyst puts SpaceX’s fair value near $780 billion, less than half the IPO ask, arguing the deal demands perfect execution and that patient investors may get a better entry after the offering. Morningstar could be wrong. But it means the IPO price should not be mistaken for proof of fair value.

There’s also a market-structure wrinkle that can muddy the early signal. Only about 7% of SpaceX will trade freely at first, and the stock is on an unusually fast path to Nasdaq 100 inclusion, roughly 15 trading days after listing. A thin float plus forced passive buying can hold the price up early, regardless of fundamentals. That can make the first trade look like a win while making the long-term entry price more dangerous, not less.

After the IPO, the Edge Fades

The single most important thing for XOVR holders to grasp is timing. The entire reason to pay up for the fund was access to something you couldn’t otherwise buy. The moment SpaceX trades under its own ticker, that scarcity evaporates. The private mark converts to a public price, validating or repricing the position in one move, and from then on anyone can buy SpaceX directly, without the fee or the other 32 holdings. The IPO that proves the thesis right is the same event that ends it. The pre-IPO upside narrative has an expiration date, and it’s measured in days.

The Technical Picture

The tape is constructive, but it isn’t the thesis. XOVR trades near $20.26, just under its $20.73 high, and holds above its main moving averages, which tells you investors are still paying up for the SpaceX catalyst. It took the June 5 market selloff in stride, dipping with tech and recovering within a session. But with the IPO days away, these levels are secondary. The real support and resistance will come from where SPCX prices its first public trades and whether XOVR’s net asset value actually benefits from the remark.

How to Position

Treat XOVR as what it is: a high-conviction, concentrated bet whose near-term value hinges on one event. These are levels to watch, not instructions.

• Pre-IPO interest zone: $18.80 to $19.70, into the moving-average cluster, where the risk/reward is less stretched for anyone who still wants the exposure and accepts the fee and the mark risk.

• Momentum trigger: a push above $20.75 would show buyers still chasing the catalyst, but it should be judged against the actual SPCX price and XOVR’s updated value, not taken at face value.

• Caution line: a close below $18 would say the uptrend has broken and the IPO optimism is draining out.

• The bigger decision: the catalyst is here, so the window for the “own it before the bell” thesis is closing. After SPCX lists, the cleaner way to own SpaceX may be SpaceX itself, not a fund where it’s one position among 33.

Bottom Line

XOVR did exactly what it promised: it gave ordinary investors a way to own a slice of SpaceX before almost anyone else could. That was a genuine edge, and for a while it was the only game in town. But the edge is fading by design.

XOVR may still work if SpaceX holds above the fund’s mark and the public-stock basket cooperates. But the cleanest part of the trade is almost over. Before the IPO, XOVR solved an access problem. After it, the question becomes whether you want to pay an active-fund fee for partial, indirect SpaceX exposure wrapped inside a concentrated growth portfolio, when you could own SpaceX outright. That’s a far less obvious trade. One number frames it: Morningstar values SpaceX near $780 billion, the IPO asks $1.75 trillion, and the market is about to decide, in public, which one it believes.

This is research and commentary, not personal investment advice. Levels are illustrative; size positions to your own risk tolerance and time horizon. The author may hold positions in the funds discussed.

Same news, same market, almost twice the drawdown. That’s not noise, it’s index design.

Friday wasn’t just a selloff. It was a reminder of what investors actually own. A hotter-than-expected May jobs report sent Treasury yields higher, revived rate-hike fears, and hit stocks hard, but the damage wasn’t spread evenly. The S&P 500 fell about 2.6%. The Nasdaq 100 fell nearly 5%. SPY and QQQ, the tradable ETFs that track those indexes, showed it in real time.

This is really a lesson in the difference between the S&P 500 and the Nasdaq 100, the broad market and its growth engine, which don’t behave the same way when rates move. Here’s what each index is, why they split apart on days like Friday, and how to think about owning them now.

Key Takeaways

• The Nasdaq 100 is roughly 100 of the largest non-financial companies, heavily tilted to technology, with about half the index in its 10 biggest names. The S&P 500 spans around 500 companies across all 11 sectors. SPY and QQQ are the ETFs that track them.

• That concentration is a feature in rallies and a flaw in selloffs. On Friday the Nasdaq 100 fell nearly twice as much as the S&P 500, a clean live example of the trade-off.

• The trigger was rates, not earnings. May payrolls came in at 172,000 against 80,000 expected, the odds of a rate hike by year-end jumped to about 73%, and the 10-year yield pushed above 4.5%.

• You pay up for the Nasdaq 100’s growth. It trades around 32 times forward earnings against roughly 22 for the S&P 500, a premium that magnifies both the upside and the drawdowns.

• Neither broke. Both slipped below their 20-day lines but held well above the levels that would signal real damage. In ETF terms, SPY’s first support sits near $723, QQQ’s near $683.

Start with what each index actually holds.

What Each Index Actually Is

• The Nasdaq 100, tracked by QQQ, holds around 100 of the largest non-financial companies listed on the Nasdaq. It is heavily tilted toward technology, communication services, and consumer growth companies. Because the index is concentrated, its largest holdings have a big influence on daily performance.

• The S&P 500, tracked by SPY, holds about 500 large US companies across all 11 market sectors. Technology is still the largest sector, but the index also includes financials, healthcare, industrials, energy, staples, and other areas of the economy. That broader mix usually makes it more diversified than the Nasdaq 100.

SPY gives you broader US market exposure. QQQ gives you a more concentrated growth and technology tilt.

Why They Move Differently

The gap comes down to concentration, valuation, and sensitivity to rates.

The Nasdaq 100 is more concentrated in megacap growth and technology companies. When those names sell off, the whole index feels it quickly. The S&P 500 owns many of the same leaders, but it also has more exposure to financials, healthcare, industrials, energy, staples, and other sectors that can help soften the move.

Rates matter too. Growth companies are valued heavily on profits expected years into the future. When bond yields rise, those future profits become less valuable today, which usually pressures the Nasdaq 100 more than the broader S&P 500.

That extra sensitivity cuts both ways. In strong markets, the Nasdaq 100 can lead. In rate scares or growth selloffs, it can fall harder. That is the trade-off: more growth exposure, more upside potential, but also more volatility.

What Just Happened, and Why It Hit Growth Harder

Friday’s selloff was a rate story wearing an equity costume. The May jobs report showed 172,000 new positions against the 80,000 economists expected, strong enough to push the Federal Reserve away from cuts and toward the possibility of another hike. The market repriced fast: the probability of higher rates by year-end jumped to about 73% from roughly 51% a day earlier, the 10-year Treasury yield climbed above 4.5%, and the 30-year pushed up to 5%. The VIX, the market’s fear gauge, spiked about 40% into the low 20s.

Higher rates are kryptonite for long-duration growth, so the damage concentrated where the valuations are richest. Chip stocks led the decline, already shaky after Broadcom declined to raise its long-term AI forecast earlier in the week, and the Nasdaq 100 posted its worst day since April 2025. The S&P 500’s broader mix, with banks that like higher rates and defensives that hold up in a scare, did what it’s built to do. It fell less.

The Technical Picture

For tradable levels, I’m using SPY for the S&P 500 and QQQ for the Nasdaq 100, since those ETFs are what investors actually buy and sell. Despite the drop, neither broke. Both spent Friday slicing below their 20-day averages, the line that tracks the short-term trend, but both held comfortably above the levels that would signal something worse.

SPY, near $737 after the drop, has its first floor at the rising 50-day average around $723, then the $710 area where a measured pullback tends to find support, and below that the 200-day near $682. Momentum reset rather than collapsed: the daily relative strength index, a 0-to-100 gauge where under 30 is washed out and over 70 is overheated, sits right at 49, dead neutral, while the weekly trend is still healthy in the mid-60s.

QQQ, near $705, is the same shape but more stretched, because it fell further. The 20-day at $718 is now overhead resistance to win back. Support steps down to the 50-day around $683, then the $675 zone, then $652 if the selling deepens. Its daily momentum gauge also sits in the high 40s, neutral after a sharp single-day flush that left the very short-term readings deeply oversold.

In plain terms: a sharp gut-check, not a trend change. The uptrends stay intact as long as the 50-day lines hold.

How to Position

These are levels to watch and zones to act around, not precise instructions, and the macro is the swing factor. If yields keep climbing, the pullback has further to run, so let price and rates settle before committing.

SPY: the core holding

• Accumulation zone: $710 to $737, from current back to the measured-pullback support. This is the broad, lower-volatility way to own the US market, and weakness toward the 50-day is usually where long-term buyers want it.

• Confirmation: a reclaim of the $744 20-day line says the scare is unwinding.

• Caution line: a close below $694, and especially the 200-day near $682, would point to a deeper correction rather than a dip.

QQQ: the growth tilt

• Accumulation zone: $675 to $705, into the 50-day and the first retracement shelf. Treat this as the higher-octane sleeve, not the whole portfolio, because it will move more in both directions.

• Confirmation: a reclaim of $718 puts it back above its short-term trend.

• Caution line: a close below $652 would say the rate scare has turned into something the growth complex can’t shrug off.

The allocation read

For most long-term investors the question isn’t the S&P 500 or the Nasdaq 100, it’s how much of each. The S&P 500 is the sensible core: the whole market, cheaper, more diversified, a smoother ride. The Nasdaq 100 is the accelerant: more growth, more tech, more reward when the cycle is kind and more pain when it isn’t. Friday was a live reminder that the growth index’s premium is rented, not owned, and the rent comes due on days like this. Size it accordingly.

Bottom Line

Friday didn’t change what either index is. It just reminded everyone, in a single session, what owning them feels like when rates bite. The S&P 500 is the market, and it fell like the market. The Nasdaq 100 is the market’s growth engine, and it fell like one, nearly twice as hard.

Neither broke, and the longer uptrends are intact above the 50-day lines. But the catalyst here is rates, not earnings, and that’s not in anyone’s control. So the discipline is simple: own the S&P 500 for the core, add the Nasdaq 100 for the tilt if you can stomach the swings, and let support levels, not headlines, decide when to step in.

Same news: the Nasdaq 100 fell 4.8% and the S&P 500 2.6%. That difference is the entire decision.

Leave a comment

This is research and commentary, not personal investment advice. Levels are illustrative; size positions to your own risk tolerance and time horizon. The author may hold positions in the funds discussed.

The tape broke hard on Friday and erased the prior week’s gains in a single session. A hot June jobs report sent yields jumping, the 2-year up 19 basis points to 4.17% and the 10-year to 4.55% from 4.45% a week ago, and the rate-sensitive end of the market repriced violently.

QQQ fell 4.8% on Friday to close the week down 4.5% at 705.06, while SPY lost 2.6% on the day and 2.5% on the week to 737.55, and both indexes lost their Trend-Hold.

The damage was concentrated where duration and beta run highest. Long-duration tech and AI names led the decline: Palantir (down 13%) and Baidu (down 10%) fell all the way from Trend-Hold to Breakdown, and the semis cohort cooled out of Trend-Hold into Transitional (AMD down 10%, Broadcom and Intel down 14%).

The high-beta and crypto complex was routed, with Redwire down 25%, the Ethereum ETF down 22%, AST SpaceMobile down 18%, the XRP ETF down 17%, and SoFi and Shopify down double digits and back into Breakdown.

Precious and industrial metals cracked as real yields rose, with gold breaking down and silver and copper miners rolling into Repair.

The tell was where money went, not just where it left: the defensive and value pockets caught a clear bid, with Oscar Health up 10%, UnitedHealth up 5%, Exxon up 3%, Walmart up 3%, and Berkshire reclaiming full Trend-Hold. This was a rates-and-valuation repricing, not a credit event: high-yield credit barely moved on the week and VIXY rose only to 24.3, elevated but far from a panic spike.

The posture for the week ahead is defensive: the broad indexes have lost their trend, breadth has rolled over, and the right stance is to respect the breakdowns, lean on the quality and defensive names that held, and demand a reclaim before re-engaging the growth complex.

What Changed From Last Week

• Reclaimed Trend-Hold: BRK.B. The strongest signal of the week, structure fully repaired.

• Cooled out of Trend-Hold into Transitional: AMD, AMZN, ASTS, AVGO, CRWV, INTC, LRCX, MSFT, QQQ, SPY, TGT, TSM, XOVR. Leaders that lost their trend and now need to re-prove it.

• Lost the trend, into Repair: ADBE, COPX, SLV. Downgraded a full step, treat as damaged until reclaimed.

• Broke down: BIDU, DG, GLD, LULU, META, NKE, NVO, PLTR, SHOP, SOFI. Fresh damage, the framework moves these to the avoid list.

• Biggest movers: OSCR +10%, PINS +7%, UNH +5%, XOM +3% to the upside; RDW -25%, ETHA -22%, ASTS -17%, XRPI -17% to the downside.

How Our Trade Plans Work

Our framework is rules-based and level-driven. We classify each name into a regime (Trend-Hold, Transitional, Repair, or Breakdown) using the 1D EMA stack, cross-checked against the 1W chart. Every entry, target, and invalidation traces back to a specific indicator level. T1 is the first profit-take layer, T2 is the structural objective, T3 is the stretch target on full continuation. Sizing follows the regime: Trend-Hold names take normal size but only on a pullback to support or a confirmed breakout; Transitional names take half size or wait; Repair names take a starter only after a reclaim; Breakdown names are avoided until a reclaim confirms.

Two stops, two jobs. The trade stop protects the position; the regime invalidation changes the thesis. The trade stop is the tactical level where a single trade is wrong and you cut it. The regime invalidation is the deeper level where the entire classification flips to a lower regime and the reason to own the name is gone. They differ on purpose: one manages risk, the other manages conviction.

Cash is a position, and waiting is part of the plan. This update ranks 60 stocks and ETFs: the highest-conviction, near-entry names get a full setup, and the rest are tracked in the watchlist table so nothing in the universe goes uncovered.

This Week’s Playbook

Start here. The detailed setups follow for the top names, and the full watchlist table covers the rest.

• Best risk/reward this week: AMAT, SMSN.L, ITA, AIXA.DE, AAPL, BRK.B (+2 more in the table). Price is already at a defined entry on the 1D EMA20, so the trigger is near and the risk is tight; these are the quality and defensive names that held their trend, the only longs worth engaging in a defensive tape.

• Best leaders to buy only on weakness: IFX.DE, PANW, RBRK, NBIS, LLY. Clean trends with room to run, but buy the pullback, do not pay up here.

• Most dangerous chase setups: none this week. After a broad selloff nothing is overbought, which is itself a measure of how much momentum was unwound.

• Avoid until a reclaim confirms: BABA, BIDU, COST, DG, ETHA, GLD, INTU, LMT, LULU, META, NFLX, NKE, NOC, NVO, PALL, PLTR, SHOP, SOFI, WMT, XRH0.L, XRPI. No long exposure; not every dip is a setup, and cash is the position.

This update covers the following 60 stocks and ETFs across consumer, technology, healthcare, industrials, and commodities.

Top 10 Actionable Setups

These are the highest-conviction names sitting closest to a defined entry. Full detail, levels, and both stops for each.

Applied Materials Inc. (AMAT), Last close: 453.01

Setup: Semi capital-equipment bellwether that held its Trend-Hold while most of the semis cooled. 1D and 1W both Trend-Hold; price above all four 1D EMAs with the 1D EMA20 at 448.98 as first support. Daily RSI 53.9 (neutral-positive), MACD bullish fading; momentum is firming, accumulate into support rather than strength. Thesis breaks on a daily close below 348.73 (23.0% below current), shifting regime to Transitional.

• Entries: Pullback:

Read more

CrowdStrike reported after the close, and for about an hour the story looked simple: a miss on billings, and a richly valued stock punished for it. The stock gapped down roughly 10% the next morning, trading as low as $671. Then something more interesting happened.

Buyers stepped straight back in and pushed it more than 7% off that low to close near $719, erasing most of the drop in a single session. In premarket it’s hovering near $714, down less than 5% from where it sat before the report.

The quarter was strong, one number wasn’t, and the market stress-tested the bad news and rejected it the same day. That round trip is the story.

Key Takeaways

• Strong quarter: revenue of $1.39B grew 26% from a year ago and beat, with non-GAAP earnings of $1.10 a share, comfortably ahead.

• Recurring revenue set a record: net new annual recurring revenue (ARR) of $256M rose 32%, lifting ending ARR to $5.51B. Management also raised guidance and approved a 4-for-1 split.

• The blemish was billings: about $1.35B, up roughly 18%, slower than revenue and ARR, and a miss. Because billings lead revenue, the market read it as a hint growth could be cooling.

• The tape rejected the bear case fast. A 10% gap down to $671 was bought back to a $719 close, leaving the stock down only modestly on the session.

• The discount is mostly gone. Near 38 times sales and still above most price targets, the easy entry has already passed, this is a “watch billings” name, not a fire sale.

Start with what CrowdStrike actually reported.

What CrowdStrike Reported

The April quarter was strong almost everywhere that matters. Revenue reached $1.39B, up 26% from a year ago and ahead of the $1.36B the Street wanted. Non-GAAP earnings came in at $1.10 a share, a clear beat.

The number management cares about most, net new ARR, set a record at $256M, up 32% from a year ago, pushing ending ARR to $5.51B. Cash generation stood out too: record operating cash flow of $591M and record free cash flow of $468M in a single quarter.

Then came the details that usually support a higher stock. Management raised its full-year revenue guide to a range around $5.94B and lifted its net new ARR growth outlook by more than 5 points.

The board also approved CrowdStrike’s first stock split, a 4-for-1, with shares distributing in early July. A split changes nothing about the value of the business, but companies tend to announce them when leadership feels good about the road ahead.

So why the gap down, and why the snap back?

Why It Dropped, and Why It Bounced

The disappointment was one forward-looking metric. Billings, the value of contracts signed and invoiced in the period, came in around $1.35B and grew roughly 18%, trailing both revenue and ARR and falling short of what analysts modeled.

Because billings tend to lead revenue by a few quarters, a soft print reads as an early sign the growth rate may be easing. In a stock that had climbed more than 60% over the past year and trades around 38 times sales, that was enough to trigger a sharp opening drop.

What happened next mattered more. Instead of bleeding lower all day, the stock found buyers right at the $671 area and recovered more than 7% into the close. Billings are lumpy, swinging with the timing of large contracts and how much customers pay upfront, so one soft quarter isn’t a thesis, and management’s raised ARR outlook argues the other way.

The market did the math in real time: a crowded, expensive stock met a single number that wasn’t perfect, panicked for an hour, then decided the franchise was worth defending. A 10% gap that closes as a 4% dip is the market telling you where the conviction sits.

The Fundamentals: Elite Cash Flow, a Premium Price

CrowdStrike’s quality isn’t in question. Gross margin runs around 75%, and the company turns roughly a quarter of its revenue into free cash flow, $1.24B over the trailing year and a record $468M in the period just reported.

The one wrinkle is that on a GAAP basis it still runs a small loss, weighed down by heavy stock-based compensation, so the honest way to value it is on sales and cash flow, not reported earnings.

On those measures it’s expensive. Even before the report, the stock traded near 38 times sales, and on a simple trailing free-cash-flow basis the multiple sits in triple-digit territory, which leaves little room for execution risk.

The brief dip to $671 trimmed the market value toward $171B and price-to-sales toward 35 times; the recovery to $714 put most of that premium straight back. The stock was already trading above the average analyst target near $571 and the median of $530 before it reported, and after the round trip it still is. This is a valuation reset that didn’t happen, not a bargain-bin moment.

The Technical Picture

A note on the levels: the daily structure now centers on the $719 close, with premarket near $714. The sequence is worth laying out, because it moved fast. Before earnings, the stock had already cooled from about $782 to a pre-report close near $748.

After the report it opened sharply lower, hit $671, then recovered to close near $719. Into the print it was extended, with the daily relative strength index, a 0-to-100 momentum gauge where readings above 70 flag an overheated move, near 69, and the weekly reading hotter, near 74.

The earnings gap drove price to $671, and buyers defended it hard, so that’s now the level that matters. It sits comfortably above the rising 20-day average near $649, which the selloff never even reached.

Overhead, the pre-report close near $748 is the gap that still needs filling, and the prior high sits at $785. Below $671, the 20-day at $649 and the 50-day near $556 are the next supports, and the trend-strength reading (a measure called ADX, where higher means a more established trend) is elevated at 53, so the larger uptrend is firmly intact. In short, it’s a strong trend that took one hit and held.

Net read: CrowdStrike remains one of the best franchises in security, and the market just showed it’ll defend the name on a bad headline. But the bounce proves buyers are still there, not that the valuation risk disappeared. At $714 you’re paying nearly the pre-report price, so the better entry is patience, a retest of the $671 gap low or the 20-day, rather than chasing the snapback.

Here’s how to approach it.

Our Trade Plan

These are zones to work around, not exact instructions, and they’re quoted in pre-split prices. After the 4-for-1 split takes effect in early July, divide each level by 4. Let price confirm before acting.

Read more

Broadcom beat on earnings, grew its AI business 143% from a year ago, guided the coming quarter well above expectations, and got sold off 15% in premarket trading the next morning. That gap between the result and the reaction is the whole story. What rattled the market wasn’t anything in the numbers. It was one thing CEO Hock Tan didn’t do: he confirmed the company’s long-term AI target instead of raising it. In a stock that had run roughly 85% over the past year into the print, “strong but not stronger” was enough to trigger heavy profit-taking. That’s an expectations reset, not a fundamental crack, and it may have handed patient investors the pullback they’d been waiting for.

Key Takeaways

• The quarter was objectively strong: revenue of $22.2B grew 48% from a year ago, accelerating from 29% the prior quarter, with non-GAAP earnings of $2.44 a share, up 54% and ahead of the $2.40 the Street wanted.

• AI is now half the company. AI semiconductor revenue hit $10.8B, up 143% from a year ago, and management guided the current quarter to about $29.4B.

• The stock was priced for perfection after an 85% run, so a beat alone was never going to be enough.

• The trigger was the outlook, not the results: Tan reaffirmed the fiscal 2027 AI target of more than $100B rather than lifting it, and a crowded trade read that as a hint the growth rate may be peaking.

• The dip is interesting, not a layup. Free cash flow was $10.26B, 46% of revenue, and the 15% gap drops the stock onto its rising 50-day line near $405. The business got cheaper on news that didn’t touch its cash flows, but it’s still expensive.

Start with what Broadcom actually reported.

What Broadcom Reported

The fiscal second quarter, ended in early May, was strong almost everywhere. Revenue came in at $22.2B, up 48% from a year ago and accelerating from the 29% pace of the prior quarter. Non-GAAP earnings were $2.44 a share, up 54% and a touch above the $2.40 consensus; on a GAAP basis the company earned $1.91, with the difference mostly stock compensation and VMware amortization.

AI is the engine. AI semiconductor revenue reached $10.8B, up 143% from a year ago, now roughly half of total sales, driven by the custom accelerators Broadcom co-designs with hyperscalers and its networking silicon.

Infrastructure software, the arm built around VMware, added $7.2B. Then came the guide that should have settled it: management pointed the current quarter to about $29.4B, with a non-GAAP operating margin near 67%.

By any normal standard, that’s a beat-and-raise. So the selloff needs explaining.

Why a Beat Sold Off

The disappointment wasn’t in the quarter. It was in the trajectory. Broadcom has guided the market to expect more than $100B of AI semiconductor revenue in fiscal 2027, and after a blowout like this, many investors were positioned for Tan to lift that bar. He didn’t. He reaffirmed roughly $56B of AI revenue for this fiscal year and reiterated the same “in excess of $100B” figure for 2027.

When a stock has nearly doubled in a year and trades at a steep premium, the bar isn’t “be great,” it’s “be greater than last time.” A reaffirmed target, however large, reads to a crowded trade as a signal that the breakneck AI growth rate may be near its peak.

That’s the real worry under the selling: not this quarter’s numbers, but how much longer the triple-digit pace can last. It’s a fair thing to watch. But notice what it isn’t.

It isn’t a cut, a miss, or a margin scare. The market is repricing its own enthusiasm, not the company’s prospects, and the early analyst response leaned toward raising price targets, not cutting them, with desks including Jefferies and Morningstar lifting their numbers even as the shares fell.

The Fundamentals After the Drop

A 15% markdown on a business this good changes the math. Before the report, Broadcom traded near 30 times sales and around 90 times trailing earnings. The gap to roughly $407 pulls the market value to about $1.93T and trims the price-to-sales multiple toward 25 times on the now-higher revenue base, with the forward earnings multiple compressing into the low-20s.

That’s still a premium, and it should be: this is a company converting 46% of its revenue into free cash flow, guiding next-quarter operating margin near 67%, and growing its most important segment at triple digits. Quality like that rarely trades cheaply, and it isn’t cheap now. It’s simply less expensive than it was a day earlier.

The one genuine caveat lives inside the drop itself: if management won’t raise the 2027 number even after a quarter like this, the growth curve may be flattening from extraordinary toward merely excellent, and a lot of future growth is already in the price. The leverage from VMware is comfortably covered by that cash flow, so the risk isn’t solvency. It’s paying up for a growth rate that fades faster than expected.

The Technical Picture

A note on the levels: they’re measured from Wednesday’s $479 close, before the after-hours report, so the structure below the price matters most right now. The roughly 15% gap takes the stock to about $407.

Into the print, Broadcom was stretched. The daily relative strength index, a 0-to-100 momentum gauge where readings above 70 signal an overheated move, sat at 73, with price pressing the top of its range.

The gap resets much of that in one move, dropping the stock from $479 onto its rising 50-day average near $405 and into the $400 to $410 support shelf. Below that, the 100-day sits near $379 and the 200-day near $349. The trend-strength reading (a measure called ADX, where higher means a more established trend) was moderate at 29, so the larger uptrend looks intact rather than exhausted.

A gap this size can take a few sessions to settle, so the first job is watching whether $400 holds.

Net read: The business got better and the stock got cheaper on the same day, for reasons that don’t touch the cash flows. Broadcom is still a premium name at a premium price, but for long-term investors already interested in it, the $400 to $410 area is where the risk/reward starts to look more interesting. A close below $360 would say something larger has changed.

Here’s how to approach it without trying to call the exact bottom.

Our Trade Plan

These are zones to work around, not exact instructions. Let price confirm before acting.

Read more

Marvell is having the kind of run that makes careers and ends them. The stock leapt 32.5% in a single session to a fresh all-time high near $291, and it’s now up more than 4x over the past year, riding a wave of enthusiasm for custom AI silicon, the application-specific chips that hyperscalers design with partners to run their own models instead of buying everything from Nvidia. The spark was a soundbite: an on-stage “next trillion-dollar company” call from Nvidia’s own CEO, which lit a fire under the whole custom-chip trade and sent Marvell vertical.

Here’s the tension. The business underneath is genuinely good and genuinely inflecting. But the stock has detached from it, running well past consensus targets and leaning on a one-time gain to make its valuation look merely expensive instead of extreme. This is a wonderful company at a dangerous price, and knowing the difference is the whole point.

Key Takeaways

• Marvell has more than quadrupled in a year and now trades above the average and median analyst target, bumping against the Street’s highest. The franchise is real; the price has run miles ahead of it.

• The immediate catalyst was narrative, but it’s attached to a real operating inflection. A “trillion-dollar” call lit the custom-chip trade, and from a market value near $255B that aspiration prices in roughly 4x more upside as near-certainty.

• The April quarter grew revenue 28% YoY to $2.42B. GAAP profit was thin at $0.04 a share (non-GAAP near $0.80), and the headline 100x earnings multiple leans on a one-time gain that lifted trailing profit above operating income.

• The tape is the most overbought I track: a weekly momentum reading near 95, price roughly 50% above its 20-day line, closing well outside its volatility bands on every timeframe.

• This is a patience trade, full stop. There’s no earnings catalyst until late August, and chasing a vertical move into thin air is how good businesses turn into bad trades.

First, what the market is so excited about.

The Business: A Real Second Winner in AI Silicon

Marvell sits in the part of the AI buildout that isn’t Nvidia’s GPUs. It designs custom accelerators and the high-speed networking and optical interconnect that move data around AI datacenters, and it’s increasingly seen as the second credible name, alongside Broadcom, that hyperscalers turn to when they want their own silicon. That’s a large and growing pool of spending, and Marvell is winning a real share of it.

The growth shows it. Revenue has climbed from a roughly $1.3B quarterly run-rate 2 years ago to $2.42B in the April quarter, up 28% YoY, with datacenter now the engine of the whole company. Over 12 quarters revenue has nearly doubled, and gross margin sits around 51%. This isn’t a story stock with no substance. The demand is here, the design wins are landing, and the top line is compounding fast.

Where it gets delicate is the bottom line.

Fundamentals: Great Top Line, Low-Quality Earnings, Stretched Price

The April quarter earned just $0.04 a share in GAAP profit, $34.5M on $2.42B of revenue. On a non-GAAP basis, which strips out stock-based compensation and acquisition amortization, it earned about $0.80, so the operating business does make real money.

Trailing 12-month numbers look healthier still, a net margin near 29% on $8.72B of sales, but that’s distorted: a one-time gain in an earlier quarter, the kind of below-the-line item that doesn’t repeat, pushed trailing net income to $2.53B, above trailing operating income of $1.43B. That doesn’t mean the gain is fake. It means the market shouldn’t capitalize it like recurring operating profit.

That matters for valuation. The friendly headline is “about 100 times trailing earnings.” Strip out the one-timer and look at operating income, and the multiple is closer to 175x. On the current quarterly run-rate, higher still.

Layer on 29x sales, a return on equity of 17%, and a free-cash-flow yield under 1%, and you’re paying a premium price for a company that’s still early in converting its growth into profit.

For contrast, Broadcom, Marvell’s larger rival in custom AI silicon, runs a 41% operating margin against Marvell’s 16%. Broadcom is already converting AI infrastructure demand into much higher operating profit; Marvell is still in the phase where the market is paying for that conversion to happen later.

The growth is here today; the profitability that would justify the multiple is mostly still ahead.

The analysts who cover it know the math. On the consensus I’m using, the stock at $291 sits above the average target near $223 and the median of $235, and depending on the data source it’s bumping against or just past the highest published target, which lands somewhere around $300 to $320. Either way, consensus sits materially below spot, which means the market is now paying for upside the desk hasn’t underwritten yet.

The balance sheet is fine (debt-to-equity of 0.29, a healthy current ratio), so this isn’t a solvency worry. It’s a “what are you paying, and for what” worry. The business is one of the best in the sector. The current earnings don’t remotely support the current price, and the bet is entirely on tomorrow.

Technicals: A Vertical Move Into Thin Air

The tape is a blow-off, plain and simple. The weekly relative strength index, a 0-to-100 momentum gauge where anything above 70 is hot, sits near 95, about as stretched as that reading ever gets.

The daily is 86. The trend-strength reading (ADX) is up near 50, which marks an exceptionally strong and mature trend rather than a fresh one.

Price at $291 is roughly 50% above its rising 20-day average near $195 and about 80% above its 50-day near $162, and it’s closing well outside the upper volatility band on every timeframe, meaning price has punched clean through the top of its expected range.

This is a near-vertical climb into a brand-new high with no overhead resistance, which sounds bullish until you remember the flip side: there’s also no nearby support to catch a fall. The first real shelf is the 20-day region, $195 to $220. Below that, the 50-day near $162 and the weekly 20-day near $150. Moves this steep rarely roll over gently.

They tend to give back a third or more in a hurry once the momentum cracks, and a weekly reading near 95 means the risk/reward has shifted from accumulation to exhaustion risk. That doesn’t mean Marvell has to revisit the $195 to $220 zone tomorrow. In a mania, extreme can get more extreme. It means that’s the first area where the risk starts to look rational again.

Net read: Marvell is one of the best stories in AI silicon attached to one of the most overextended tapes in the market. The franchise deserves a premium; it doesn’t deserve a weekly RSI of 95 and a price that’s outrun consensus. Don’t chase it here. Want it lower, $195 to $220, with a close back below $178 the line that says the leg has truly broken.

Here’s how to act on that without overpaying.

Our Trade Plan

These are zones to work around, not exact instructions. Treat the levels as areas where the odds shift, and let price confirm before acting.

Read more